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Pediatric Healthcare Providers’ Screening Practices: Impact of Training on Early
Identification of Autism
Aja M. Meyer
ABSTRACT
This study explored the effectiveness of the Autism System of Care (ASC)
trainings by measuring change in pediatric healthcare providers’ method of identifying
young children at-risk for autism spectrum disorders. The majority of participants were
pediatricians working in either hospitals or clinics who voluntarily participated in the
training. A pretest-posttest nonequivalent-groups design was used in this study. Pre- and
post-test questionnaires were used to measure change in participants’ screening practices.
Due to a small number of participants, most findings from the study were not statistically
significant. The small number of healthcare providers who participated in the ASC
training was a major limitation to this study. Therefore, although results revealed that
there were minimal gains between pre- and post-test administrations, this may be because
of the small number of participants and does not necessarily indicate that the ASC
training was not effective. Implications for future research in this area also are addressed.
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Chapter 1
Introduction
Statement of the Problem
Autism is a lifelong developmental disability that affects the functioning of the
brain and typically appears during the first three years of life. Autism falls under the
category of Autism Spectrum Disorders (ASD), which refers to the broad continuum of
cognitive and neurobehavioral difficulties present in these individuals (American
Psychiatric Association, 2000). The fundamental features of autism are the presence of
markedly abnormal or impaired development in communication and social interaction, as
well as a distinctly restricted repertoire of behaviors and interests (Chakrabarti &
Fombonne, 2001; Klinger, Dawson, & Renner, 2003; Oser & Shaw, 2001). Appearance
of the disorder varies greatly depending on the developmental level and chronological
age of the individual (Chakrabarti & Fombonne, 2001). The occurrence of autism is
thought to be on the rise, with the latest studies finding higher rates than what was found
in studies conducted in the 1980s and early 1990s. Earlier studies found that
approximately 4 per 10,000 children had autism, while a study in 1998 found that 40 per
10,000 children have autistic disorder, with the number increasing to 67 per 10,000 if all
types of autism-like behaviors are included (Yeargin-Allsopp et al., 2003).
Although the exact cause of autism spectrum disorders is still unknown, the
literature reports that children with autism spectrum disorders (ASD) show more
significant gains when they receive supports and services early on in their development.
1

However, many children are not being identified as early as possible to obtain the
benefits of early intervention (Baird et al., 2000; Scambler, Rogers, & Wehner, 2001). It
is estimated that only 50% of children with ASD are diagnosed before kindergarten
(Strock, 2004). The diagnosis of ASD may be delayed due to concerns about labeling a
child or incorrectly diagnosing a child (Filipek et al., 2000; Oser & Shaw, 2001).
Although approximately 25% of children in primary care practice have developmental
delays, less than 30% of primary care providers routinely conduct screening tests at wellchild visits (Dworkin, 1989; Filipek et al., 2000).
Research indicates that early diagnosis is associated with dramatically better
outcomes for individuals with autism because an accurate diagnosis and early
identification can provide the basis for building an appropriate and effective educational
and treatment program. In addition, early intervention facilitates earlier educational
planning, provisions for family supports and education, management of family stress, and
the distribution of appropriate medical care (Filipek et al., 2000). Because early
educational intervention is the key to helping children with autism develop into
competent and productive adults, routine early screenings of children are imperative so
that they receive the various services needed in a timely manner. While no one behavioral
or communications test can detect autism, several screening instruments such as the
Parents’ Evaluations of Developmental Status (PEDS), the Checklist for Autism in
Toddlers (CHAT), and the Pervasive Developmental Disorder Screening Test (PDDST)
have been developed that are now used to identify young children who may be at-risk for
ASD (Prater & Zylstra, 2002).
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Given that typically developing children demonstrate eye contact, orienting to
one’s name, joint attention, pretend play, imitation, nonverbal communication, and
language development by 18 months of age, experienced professionals can reliably
diagnose autism in children as young as 18 months of age (Filipek et al., 1999). In
addition, autism-specific screening instruments have been developed for use with
children at 18 months of age (e.g., CHAT). Pediatricians generally see young children on
a regular basis throughout the first two years of life; therefore, they typically are involved
in screening, identifying, and referring patients who are suspected of having an ASD for
further evaluation.
Unfortunately, pediatric healthcare providers perceive a number of barriers to the
utilization of screening instruments with young children. Several frequently reported
barriers include providers’ unfamiliarity with the early warning signs of autism,
inadequate time to perform developmental screenings during typical well-child visits, and
unfamiliarity with screening instruments (Halfon et al., 2001). Therefore, it is imperative
that pediatric healthcare providers’ knowledge-base of screening instruments and ASD be
improved (Filipek et al., 1999). Professionals need to be knowledgeable about the early
symptoms of autism as well as the available, score-validated screening instruments so
that appropriate screening and referral procedures may occur.
Theoretical Framework
To be most successful in identifying young children with autism spectrum
disorders, it is important to use an ecological model of child development, such as Urie
Bronfenbrenner’s framework, which takes into account biological, sociological, and
psychological domains (Sontag, 1996). When using an ecological model, a variety of

3

measures are utilized in assessing the disorder. From a developmental perspective, the
disorder is viewed within a conceptual framework that considers the expectations of
children at particular ages. Utilizing the ecological model, the pediatric healthcare
provider obtains a developmental history, a medical evaluation, behavioral
observation(s), and information related to cognitive functioning and language ability to
identify children at-risk for ASD.
In addition, when making decisions that will impact children’s continued
development, it is of the utmost importance to utilize data-based decision making. The
general steps used in data-based decision making are: (a) establish a team, (b) develop a
hypothesis, (c) gather data to assess needs, (d) use data to formulate goals, (e) develop a
data-based plan, and (f) monitor progress and document success (Yang & Goldstein,
1999). When pediatric healthcare providers utilize an ecological framework to enhance
their understanding of child development and employ data-based decision making, their
young patients are more likely to receive the early intervention supports and services they
need to maximize their development (Filipek et al., 2000).
Purpose of the Study
Although a great deal of research supports the notion that early identification of
autism spectrum disorders leads to better outcomes, a large number of children with ASD
still are not identified as early as possible. Furthermore, the recent increase in the number
of individuals diagnosed with ASD heightens the importance of early identification. To
this end, this study attempted to discover the effectiveness of the Autism System of Care
(ASC) trainings by measuring change in pediatric healthcare providers’ method of

4

identifying young children at-risk for autism spectrum disorders. Pre- and post-test
questionnaires were used to measure change in participants’ screening practices.
Research Questions
The following research questions were addressed in this study:
1. What is the effect of the Autism System of Care (ASC) training on use of
developmental and autism-specific screening instruments by pediatric healthcare
providers?
2. What is the effect of the ASC training on the use of developmental screening
instruments in regard to age of patient?
3. What is the effect of the Autism System of Care training on pediatric healthcare
providers’ perceived barriers to increasing the use of screening instruments and/or
referring patients?
4. What is the effect of the Autism System of Care training on pediatric healthcare
providers’ perceived levels of knowledge related to Autism Spectrum Disorders?
5. What is the effect of the Autism System of Care training on the self-efficacy of
pediatric healthcare providers regarding the ability to screen accurately and refer a
child suspected of having an Autism Spectrum Disorder?
6. What is the relationship between pediatric healthcare providers’ perceived barriers
to utilizing screening instruments and their actual use of developmental and
autism-specific screening instruments before and after completion of the training?
7. What is the relationship between perceived barriers to utilizing screening
instruments and the use of developmental screening instruments in regard to age
of patients before and after completion of the training?

5

Hypotheses
The following research hypotheses were tested in this study: (a) Autism System of
Care (ASC) training increases pediatric healthcare providers’ routine use of
developmental screening instruments and autism-specific screening instruments, (b) ASC
training increases pediatric healthcare providers’ routine use of developmental screening
instruments with patients at younger ages than the ages of patients at screening prior to
completion of the training, (c) ASC training decreases pediatric healthcare providers’
perceived barriers to the use of screening instruments and/or referring patients, (d) ASC
training increases pediatric healthcare providers’ general knowledge related to ASD (e.g.,
early warning signs and score validated screening instruments), (e) ASC training
increases pediatric healthcare providers’ perceived self-efficacy regarding their ability to
screen and refer children suspected of ASD, (f) ASC training decreases pediatric
healthcare providers’ perceived barriers to utilizing screening instruments while
increasing their use of developmental and autism-specific screening instruments, and (g)
ASC training decreases pediatric healthcare providers’ perceived barriers to utilizing
screening instruments while increasing their use of developmental screening instruments
with patients at younger ages than the typical age at screening prior to completion of the
training.
Significance of the Study
This study provides valuable information about the effectiveness of the Autism
System of Care trainings in changing pediatric healthcare providers’ method of the early
identification of children at-risk for ASD. Because the benefits of early intervention have
been well documented in the literature, the early identification of ASD is crucial for
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optimal outcomes for these children (Filipek et al., 1999). Young children with ASD and
their families will benefit greatly from early intervention services, and pediatric
healthcare providers play a critical role in the early identification of these disorders. The
Autism System of Care trainings also may play a significant role in enabling pediatric
healthcare providers to identify children with ASD early in their development.
Definition of Terms
Autism Spectrum Disorders. Autism Spectrum Disorders (ASD) also are known as
Pervasive Developmental Disorders (PDDs). These disorders are typically diagnosed in
early childhood and cause pervasive impairment in thinking, feeling, language, and the
ability to relate to others (Strock, 2004). There are five disorders, each with different
levels of severity, that fall under ASD: (a) autistic disorder (a severe form), (b) pervasive
development disorder not otherwise specified (PDD-NOS) (a mild form), (c) Asperger
syndrome (a milder form), (d) Rett syndrome (a rare, severe form affecting females), and
(e) childhood disintegrative disorder (a rare, severe form) (Strock, 2004).
Early identification. Early identification refers to the detection of ASD and/or other
disabilities early on in children’s development (Filipek et al., 2000).
Evaluation. An evaluation is the process of determining whether an individual is eligible
for early intervention or special education services (Oser & Shaw, 2001).
Screening. A screening is a brief, point-in-time procedure for deciding which individuals
need a referral for further assessment (Oser & Shaw, 2001).
Organization of Remaining Chapters
The remaining chapters present information that is pertinent to this study. More
specifically, Chapter 2 provides a thorough review of the related literature, discussing
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ASD and the process of identification, screening, and diagnosis. Furthermore, the role of
pediatric healthcare providers in the early identification of ASD is reviewed, including a
discussion of the perceived barriers to early identification and the utilization of screening
instruments. Chapter 2 concludes with a discussion of the importance of training to
facilitate change in service delivery for pediatric healthcare providers so they are better
able to identify young children with ASD. Chapter 3 details the methodology that was
used in this study, including sampling, instrumentation, procedures, and data analysis.
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Chapter 2
Review of the Related Literature
Overview
This chapter provides a review of the literature relevant to this study. Autism
spectrum disorders (ASD) are discussed, including the prevalence/incidence,
symptomatology, and potential causes. The importance of early identification and
intervention is discussed, as well as the screening and identification processes for ASD,
including a review of screening instruments and procedures. The role of pediatric
healthcare providers in this process is presented, and both supports for and barriers to the
developmental screening process are presented. This chapter concludes with a discussion
of the importance of training pediatric healthcare providers in relation to changing
practices effectively, thereby better enabling practitioners to identify children with ASD
as early as possible.
Autism Spectrum Disorders
Autism, a complex neurodevelopmental disorder that affects the functioning of
the brain, is the most prevalent disorder that falls under the category of “Autism
Spectrum Disorder” (ASD). Autism is considered a spectrum disorder because the
symptoms and characteristics can present themselves in a wide variety of combinations,
from mild to severe. Although ASD is defined by a certain set of behaviors, individuals
can exhibit any combination of the behaviors in any degree of severity. The diagnostic
category of ASD includes five disorders with different levels of severity: (a) autistic
9

disorder, (b) pervasive developmental disorder--not otherwise specified (PDD-NOS), (c)
Asperger syndrome, (d) childhood disintegrative disorder (CDD), and (e) Rett syndrome
(American Psychiatric Association [APA], 2000). In the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (Text Revision) (DSM-IV-TR), “autistic
disorder” is listed under the heading of “Pervasive Developmental Disorders” (APA,
2000).
Autistic disorder is diagnosed when an individual displays a total of 6 or more of
12 symptoms listed across three major areas: social interaction, communication, and
behavior (APA, 2000). Specifically, at least two symptoms must fall under the category
of qualitative impairment in social interaction, such as marked impairment in the use of
multiple nonverbal behaviors and/or lack of social or emotional reciprocity. At least one
symptom must fall under the category of qualitative impairments in communication, such
as marked impairment in the ability to initiate or sustain a conversation with others and/or
lack of varied, spontaneous make-believe play. Finally, at least one symptom must fall
under the section of restricted, repetitive, and stereotyped patterns of behavior, interests,
and activities, such as apparently inflexible adherence to specific, nonfunctional routines
or rituals and/or stereotyped and repetitive motor mannerisms (APA). In addition, there
must be delays or abnormal functioning in at least one of the above mentioned areas
(social interaction, language as used in social communication, and symbolic or
imaginative play) with onset prior to age 3 years. A diagnosis of Pervasive
Developmental Disorder--Not Otherwise Specified (PDD-NOS) is given when children
display similar behaviors but do not meet the criteria for autistic disorder (APA, 2000).
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This study will focus on two of the disorders, autism and PDD-NOS, because they
are two of the more prevalent disorders under the diagnostic category of ASD (Oser &
Shaw, 2001). In addition, autistic disorder and PDD-NOS have symptomatology that
allow for earlier identification and intervention (Oser & Shaw, 2001). For the purpose of
this review of the literature, the author will use the term “autism” to encompass both
autistic disorder and PDD-NOS. Additionally, the term “Autism Spectrum Disorder”
(ASD) will be used in place of “Pervasive Developmental Disorder” because it is
considered to describe more fully the continuum of symptoms presented by young
children (Oser & Shaw, 2001).
Prevalence/Incidence
It is important to differentiate prevalence from incidence when discussing the
increase in the reported cases of autism. Prevalence refers to the proportion of individuals
in a population who suffer from a defined disorder, whereas incidence refers to the
number of new cases occurring in a population over a period of time (Fombonne, 2003).
It should be noted that both prevalence and incidence estimates will be inflated when the
definition of ASD is broadened and diagnostic instruments are improved. Two recent
studies (Kaye et al., 2001; Powell et al., 2000) have provided incidence estimates that
showed an increasing trend over a brief period of time; however, neither study examined
changes in diagnostic criteria or sensitivity of case detection procedures during this time
period (Fombonne, 2003). Therefore, the recent increase in rates of prevalence cannot be
directly attributed to an increase in incidence of ASD. Further research is needed to test
hypotheses accurately on changes in the incidence and prevalence of ASD (Fombonne,
2003).
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Although autism was once thought to be a fairly rare disorder, it is more prevalent
in the pediatric population than cancer, diabetes, spina bifida, and Down syndrome
(Filipek et al., 1999). The apparent increase in the incidence and prevalence of autism
spectrum disorders has led to increased concern about the disorder (Chakrabarti &
Fombonne, 2001; Yeargin-Allsopp et al., 2003). Early studies conducted by Lotter (1966)
and Wing and Gould (1979) found that approximately 4 per 10,000 children had autism,
while a study by Bertrand et al. (2001) found that 40 per 10,000 children had autistic
disorder, with the number increasing to 67 per 10,000 if all types of autism-like behaviors
are included. Similarly, Baird et al. (2000) found a rate of autism of 30.8 cases per
10,000; however, the rate increased to 57.9 cases per 10,000 for all autism spectrum
disorders. A number of recent studies have examined the prevalence of ASD, with
considerable variability in their results. For instance, Filipek et al. (2000) estimated that
ASD occur at a rate of 20 in 10,000 children, whereas Chakrabarti and Fombonne (2001)
reported that ASD are estimated to occur in as many as 60 in 10,000 individuals.
Gillberg and Wing (1999) in their meta-analysis found an increase in prevalence,
from 4.7 cases per 10,000 in children born prior to 1970, to 11.2 cases per 10,000 in
children born in 1970 and later. Although the rise in the number of individuals diagnosed
with autism is supported by the literature, it is still unclear whether the increase in autism
is strictly due to an increase in prevalence, or if the increase reflects improved awareness
and diagnostic instruments available for ASD (Klinger, Dawson, & Renner, 2003). The
observation of these noticeably increasing prevalence rates supports the necessity for
improved early screening and diagnostic procedures (Filipek et al., 1999).
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Autism is approximately four times more prevalent in males than in females, with
a male/female ratio of 4.3:1 (Fombonne, 2003). However, the ratio appears to vary with
IQ, ranging from 2:1 in those with severe dysfunction to more than 4:1 in those with
average IQ scores (Filipek et al., 1999). There are no significant differences in prevalence
or symptomatology of ASD when comparing diverse racial, ethnic, and social groups.
Furthermore, socioeconomic factors, lifestyle choices, and educational levels do not
appear to affect the chances of ASD occurrence, making it an equal-opportunity disorder
(Fombonne, 2003). Autism is considered a universal disorder, as studies throughout the
world have reported consistent symptomatology, intellectual functioning, gender
differences, and socioeconomic factors (Fombonne, 2003; Klinger et al., 2003).
Symptoms/Indicators
Autism is characterized by pervasive impairment in thinking, feeling, language,
and the ability to relate to others. More specifically, impairments in reciprocal
communication skills, atypical language development, and a restricted and repetitive
range of behaviors are commonly present. It is unclear whether these different areas of
development are intrinsically linked, whereby impairment in one area leads to difficulties
in other areas. However, Klinger et al. (2003) report that it is probable that a group of
deficits, rather than one primary deficit, affect these areas of development in young
children.
The social symptoms that are commonly impaired in ASD include the ability to
share attention with another individual, to understand another person’s emotions (this
concept is termed “theory of mind” in the literature), and to engage in pretend play.
Because the development of early social abilities is considered to be a precursor to
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language development, children with autism also tend to experience a significant delay in
this area (Klinger et al., 2003). As both verbal and nonverbal communication skills may
be impaired by autism, greater understanding is needed of both normal and abnormal
development in this area (Bristol-Power & Spinella, 1999).
Wetherby et al. (2004) examined warning signs of ASD in the second year of life.
They found that young children with ASD are likely to be delayed in using words and
their vocalizations are likely to lack consonants and to have atypical prosody. In addition,
children with ASD are not likely to respond to their name or to instructions even with
contextual cues (Wetherby et al.). These children are likely to be delayed in using objects
conventionally in play and also are likely to display repetitive movements with their body
and/or objects. Moreover, young children with ASD are typically delayed in sharing
attention with eye gaze, sharing affect, and drawing others’ attention to objects or events
of interest (Wetherby et al.). Additionally, gestures of pointing and showing, and a lack
of coordination of gestures with eye gaze, facial expression, or vocalizations is evident in
children with ASD. However, it is important to note that some of these warning signs
also are seen in children with developmental delay (Wetherby et al.).
Numerous studies have demonstrated deficits in joint attention skills of children
with ASD. These deficits include difficulties using eye gaze to coordinate attention,
following the attentional focus of another person, and drawing another’s attention to an
object or event of interest (Mundy, Sigman, & Kasari, 1990; Stone, Ousley, Yoder,
Hogan, & Hepburn, 1997; Wetherby, Prizant, & Hutchinson, 1998). Longitudinal
research findings suggest that the failure to acquire gestural joint attention may be a core
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deficit in ASD and a critical milestone that impairs language development (Mundy et al.,
1990; Sigman et al., 1999).
Repetitive behaviors are commonly seen in children with autism, and these
behaviors typically fall into one of two categories. The first category comprises lowerlevel behaviors that present repetitive motor movements; the other category consists of
higher-level behaviors in which an individual is insistent on following a specific routine
or holds a very narrow range of interests (Turner, 1999). Several other behavioral
symptoms are often related to autism. Self-injurious behavior, such as head banging, hair
pulling, and hand biting, is typically seen in lower-functioning individuals with autism. In
addition, sleep disturbance, eating disturbance, and excessive anxiety also can occur with
autism (Klinger et al., 2003).
Potential Causes
Currently, the etiology of autism spectrum disorders is unknown. Therefore,
interventions are structured to reduce the interfering symptoms of ASD. Clinicians
initially believed autism was caused by cold, rejecting parents from wealthy families. In
particular, mothers were often blamed for the child’s condition; therefore, the term
“Refrigerator Mom” was used to describe these mothers (Bettelheim, 1967). However,
this notion does not hold merit in the current literature. Autism was once viewed as a
psychogenic disorder; however, compelling evidence now suggests that autism is a
disorder of abnormal brain development that is largely genetic. A number of family and
twin studies has revealed that genetic factors play a role in the occurrence of ASD
(Rutter, 2000).
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Nicolson and Szatmari (2003) reviewed the findings from a number of genetic
and brain-imaging studies of autism over the past 15 years. The findings were
synthesized, and overwhelming evidence was found to support a neurobiological basis for
autism. The risk to siblings of children with autism is approximately 50 to 100 times
greater than the risk to the general population. However, these statistics only provide
evidence that the disorder runs in families. To determine whether the basis of the familial
aggregation is environmental or genetic, twin studies must be conducted. Several twin
studies have revealed much higher concordance rates for monozygous than dyzygous
twins. These findings indicate the presence of significant genetic factors, with heritability
estimates greater than 90%, which make ASD the most heritable of the psychiatric
disorders (Szatmari, Jones, Zwaigenbaum, & MacLean, 1998). Nicolson and Szatmari
(2003) concluded that the likely cause of autism is a genetic defect in the control of
neurodevelopment, resulting in structural and functional changes predisposing an
individual to autism. Although evidence is continuing to accumulate for an underlying
genetic cause for ASD, more research must be conducted in order to determine its
etiology. Given that there is currently no biological marker for ASD, screening and
diagnosis must be based on behavioral features (Filipek et al., 1999). The consistent use
of screening instruments that yield valid information for the detection of children at risk
for ASD likely will lead to earlier and improved interventions for children with ASD
(Filipek et al., 1999).
Importance of Early Identification and Intervention
The early identification of autism spectrum disorders leads to better gains for
these children if supports and services are initiated early on in development. Although
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substantial literature provides support for the positive effects of early identification, many
children with ASD are not identified nor supported as early as possible to benefit from
early intervention services (Oser & Shaw, 2001). Professionals such as developmental
pediatricians, child neurologists, and child psychiatrists are typically knowledgeable
about ASD and have experience working with children who have these disorders.
Therefore, these clinicians are frequently involved in assessing, diagnosing, and treating
children with ASD (Oser & Shaw, 2001).
Evidence is growing that demonstrates the effectiveness of intensive early
intervention with a significant proportion of young children with ASD (Dawson &
Osterling, 1997; Filipek et al., 2000; Oser & Shaw, 2001). Dawson and Osterling (1997)
reviewed eight model preschool intervention programs for children with autism that have
been operating since the 1980’s. The findings suggest that many children with autism
who receive early intervention services make significant developmental gains. These
gains were measured by the programs in a variety of ways (e.g., IQ scores, developmental
scores on standardized tests, observational measures taken in the classroom). Because of
the variation in measures used, it is difficult to compare the outcomes of these different
programs; therefore, a general analysis of the overall progress of the 150 children in the
early intervention programs was completed (Dawson & Osterling, 1997). All of the
programs were effective in fostering significant developmental gains, as well as positive
school placements (e.g., these children are frequently able to be included in general
education classrooms by the time they begin elementary school).
Dawson and Osterling (1997) discovered that as long as certain fundamental
program features are present, children tend to have favorable outcomes regardless of the
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specific philosophy of the intervention program. Although the majority of children with
autism who receive early intervention services make gains, it is still unclear whether the
rate of progress is related to child characteristics such as IQ and language ability
(Dawson & Osterling, 1997). Children from all eight preschool programs made, on
average, an IQ gain of approximately 20 points. Although the majority of the children
participating in the program had an IQ score in the mental retardation range (< 70) at the
beginning of the program, most of the children responded positively to early intervention,
making considerable progress. Dawson and Osterling (1997) concluded that further
research must be conducted to determine whether one intervention approach is more
effective than another, and to ascertain the most appropriate early intervention program
intensity level.
The contention that early experience is important for promoting the most
favorable long-term outcomes for children with developmental disabilities has been
supported by studies of behavioral outcomes and early intervention in various at-risk
populations (Dawson, Ashman, & Carver, 2000). The growing literature in the area of
biological research indicates brain development begins prenatally and continues
throughout the first few years of life. This information suggests that there may be a
“sensitive period” whereby early intervention services would have a significant impact on
behavior outcomes for children with ASD (Dawson et al., 2000). As research and policy
have emphasized the significance of early experience in the development of young
children, new techniques for studying infant behavior and brain activity have been
developed. These latest procedures have allowed researchers to learn more about the
relationship between biology and behavior in infants and young children. Early
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development in children consists of many fundamental “experience expectant” processes,
whereby children are anticipated to meet certain milestones (Dawson et al., 2000, p. 706).
However, genetic or acquired brain abnormalities in ASD preclude these children from
obtaining normal experiences in otherwise normal environments (Dawson et al., 2000).
Dawson et al. (2000) concluded that because the prenatal and early postnatal
years represent a sensitive period with respect to the long-term beneficial effects of early
intervention on brain and behavioral development, increased efforts at early identification
are needed. Although prevention and early intervention efforts should not focus only on
the earliest years of development, it is apparent from the extensive research that these
efforts should begin as early as possible. Because long-term negative consequences have
their greatest influences during early development, with the promotion of optimal
prenatal and infant–toddler development, these negative consequences can be minimized
or avoided completely. In addition, greater public awareness and education of healthcare
providers in regard to the early detection of developmental disorders and how to access
appropriate interventions are needed. Providers need to be proficient in the identification
of early symptoms of autism so that appropriate screening and referral procedures can
occur.
Research indicates that intervention provided before 3.5 years of age has a greater
impact than interventions begun after five years of age (Filipek et al., 2000; Harris &
Handleman, 2000). Harris and Handleman (2000) conducted a study examining the
predictive power of age and IQ at the beginning of an early intervention program using
applied behavior analysis. The children who participated in the intervention program at
the Douglass Developmental Disabilities Center were examined in a 4- to 6-year follow-
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up after they left the preschool. At the start of the program, 27 children with autism
between the ages of 31 and 65 months had IQ scores between 35 and 109 on the Stanford
Binet. Harris and Handleman found that children with both higher IQ scores (M = 78) and
younger age at intake (M = 42 months) were predictive of being in a general education
class after completion of the program. Children who had lower IQ scores (M = 46) and
were older at intake (M = 54 months) were strongly associated with placement in special
education classrooms. These results support the necessity for early intervention services
for children with ASD. However, Harris and Handleman emphasized that both children
with lower IQ scores and older children also showed measurable gains in IQ scores from
treatment. Harris and Handleman concluded that although receiving intervention services
at a very young age is most beneficial, older children also respond quite favorably to
intervention services.
Research on social communication has important implications for earlier
identification and intervention in young children with ASD because the skill deficits
identified are skills that typically develop during the first 12 to 18 months of life. These
findings suggest that there may be a set of pre-linguistic behaviors (e.g., gaze/point
following, shared affect, gestures, communicative vocalizations, symbolic play) that are
important early indicators of ASD. These behaviors also may help to distinguish children
with ASD from both typically developing children and children with other developmental
delays (Wetherby et al., 2004).
The substantial effect of early intervention has been dramatically demonstrated in
the case of autism spectrum disorders. If intensive behavioral interventions are initiated
by 2 years of age, a substantial number of children with autism show remarkable
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improvements in their development (Dawson & Osterling, 1997). These findings suggest
there is an urgent need to improve early identification so that children with ASD are able
to access interventions as early as possible (Wetherby et al., 2004).
The Individuals with Disabilities Education Act (IDEA) was created to ensure
that young children with disabilities receive early supports and services. IDEA is a law
that guarantees all children with disabilities access to a free and appropriate public
education. However, according to the 23rd annual report to congress on the
implementation of the IDEA (U.S. Department of Education, 2001), young children with
developmental delays, including those with ASD, appear to be under-identified and
underserved. In the United States from 1999 to 2000, approximately 1.8% of children
under the age of 3 years received early intervention services under the Individuals with
Disabilities Education Act (IDEA) Part C; however an estimated 5% of preschoolers
were served under Part B of IDEA. These data indicate that a considerable proportion of
children under the age of 3 years with developmental delays such as ASD are not
identified or fail to receive early intervention services.
Challenges to Early Identification and Intervention
The National Early Childhood Technical Assistance System (NECTAS) has
assisted states in identifying and addressing the challenges related to the early
identification of children with ASD, including the importance of building the knowledge
base on effective practices (Oser & Shaw, 2001). To attend to these challenges, the
NECTAS Forum on ASD was created. This group of policy-makers identified national
issues and promising practices in state early intervention and preschool special education
systems. Through the use of focus groups, conference calls, web-based discussion
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forums, and survey research, NECTAS identified promising practices in state early
intervention and preschool special education systems (Oser & Shaw, 2001). In 1999, a
survey to identify challenges to the early identification of ASD was mailed to 126 statelevel policy makers. Thirty-five coordinators responded (27.8%), identifying challenges
such as developing policies for public awareness and early intervention, involving parents
in the identification process, and providing information to parents regarding the process
of evaluations. The lack of appropriate tools and techniques available to identify young
children with ASD was reported to be a challenge to early identification as well.
Information derived from the NECTAS Forum on ASD activities will aid in the
development of future strategies in early intervention and preschool special education
systems (Oser & Shaw, 2001).
The NECTAS Forum on ASD discussed specific challenges and strategies for
earlier identification, including (a) raising public and professional awareness, (b) tools for
screening, (c) determining eligibility for services, and (d) transition. Raising public and
professional awareness involves increasing the awareness of warning signs of ASD
among primary healthcare providers as well as the public. This awareness can be
accomplished by developing an early identification campaign that includes ASD,
providing resources and training for primary healthcare providers as well as recent
practice parameters, and extending awareness efforts to include places such as schools,
child care centers, and child welfare agencies. Tools for screening refers to the use of a
multi-stage process for early identification, the routine screening for early language
development, and the distribution of information on early warning signs for ASD to
primary referral sources. The NECTAS Forum on ASD also discussed the importance of
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awareness and training regarding screening tools (e.g., Checklist for Autism in Toddlers
[CHAT]), and the dissemination of information about screening instruments available for
milder disorders in the spectrum. Determining eligibility for services refers to the
development of guidelines for evaluation and assessment procedures. In addition, the
NECTAS Forum on ASD recommended more frequent re-evaluations and follow-up of
children with ASD, with children diagnosed with PDD-NOS being re-evaluated before
the age of 3 years. Finally, transition refers to the planning of transitions (e.g., from early
intervention program into preschool classroom) as soon as possible, and collectively
addressing assessment and evaluation issues among various personnel (e.g., Part C and
Part B of IDEA) (Oser & Shaw, 2001).
Screening Instruments and Procedures
Developmental screening is intended to identify young children who may need
more comprehensive evaluations to assess their development; therefore, it is
recommended by the American Academy of Pediatrics (AAP) that all infants and
children are screened for developmental delays or disabilities (AAP, 2001). The use of
developmental screening instruments is an efficient way to record observations and help
providers identify more children with developmental delays (AAP). Some research
suggests that although a number of screening tools are available for identifying ASD in
young children, the disorders may often remain unrecognized and undiagnosed because
suitable tools for routine developmental screening and autism-specific screening remain
unavailable (Filipek et al., 1999).
However, the National Research Council Report on Educating Children with
Autism (2001) reviewed several screening instruments for the detection of ASD. The
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Checklist for Autism in Toddlers (CHAT) has been score validated, and the Modified
Checklist for Autism in Toddlers (M-CHAT), the Ages and Stages Questionnaire (ASQ),
and the Pervasive Developmental Disorders Screening Test (PDDST) are in the process
of being score validated. In addition, NECTAS reported that developmental screening
instruments, such as the Parents’ Evaluation of Developmental Status (PEDS), can
accurately provide information about their child’s development.
Developmental Screening Instruments
Both general developmental and autism-specific score-validated screening
instruments can play a significant role in the earlier identification of young children with
ASD (AAP, 2001; National Research Council, 2001). General developmental screening
instruments have a wide application with children of varying ages, allow flexibility to
obtain parental report with minimal assistance, ask more universal questions of parents,
and coordinate with typical developmental milestones. However, due to their broad use,
these instruments often lack the sensitivity to screen specifically for autism. Therefore,
when results of general developmental screening tools raise concern, follow-up with
autism-specific screening instruments is required. General developmental screening
instruments that were reviewed in the ASC trainings include the Ages & Stages
Questionnaire (ASQ; Bricker & Squires, 1999), the Parents’ Evaluations of
Developmental Status (PEDS; Glascoe, 1998), and Communication and Symbolic
Behavior Scales Developmental Profile Infant Toddler Checklist (CSBS DP Infant
Toddler Checklist; Wetherby & Prizant, 2002).
Ages & Stages Questionnaire (ASQ). The ASQ uses parental report for children
birth to five years of age. The questionnaire can be administered at a number of age
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intervals, from 4 to 60 months. The questionnaire takes approximately 10-15 minutes for
parents or caregivers to complete, and 2-3 minutes to score. Developmental areas
including communication, gross motor, fine motor, problem solving, and social are
addressed. The ASQ provides clear drawings and directions for eliciting thoughtful
responses, and separate forms for each age range of 10 to 15 items are tied to the well
child visit schedule. The ASQ provides pass or fail scores, and has been wellstandardized and score validated with good sensitivity and excellent specificity (Filipek
et al., 1999).
Parents’ Evaluations of Developmental Status (PEDS). The PEDS is a screening
and surveillance tool used with children from birth to eight years of age. It allows
clinicians to make evidence-based decisions and is designed to detect a wide range of
developmental issues as well as various types of parental concerns. The PEDS identifies
when to refer for additional screening or monitor developmental progress. The tool
promotes collaboration between parents and providers by eliciting parents’ concerns. The
parents respond to 10 carefully constructed questions, with 90% of parents completing
the written questionnaire while waiting for their appointment. Approximately two
minutes are needed to score and interpret the results (Filipek et al., 1999). High,
moderate, or low-risk scores are obtained for developmental and behavioral problems.
The sensitivity for the PEDS ranges from 74%-79% and the specificity ranges from 70%80% across age levels (Filipek et al., 1999).
Communication and Symbolic Behavior Scales Developmental Profile Infant
Toddler Checklist (CSBS DP). The Communication and Symbolic Behavior Scales
Developmental Profile (CSBS DP; Wetherby & Prizant, 2002) is a standardized
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instrument designed for routine screening and evaluation of communication and symbolic
abilities. This tool was designed for children between 12 and 24 months of age to assess
typical communication milestones and parental concern regarding development. The
CSBS DP was developed based on the Communication and Symbolic Behavior Scales
(CSBS; Wetherby & Prizant, 1993), which is a more in-depth tool designed for program
planning. The CSBS DP is a brief questionnaire consisting of a 24-item Infant-Toddler
Checklist for screening that can be completed by a parent. A longer follow-up Caregiver
Questionnaire is available as well as a Behavior Sample. The Behavior Sample consists
of a face-to-face evaluation of the child interacting with a parent and physician that is
videotaped for later analysis. These three components (Checklist, Caregiver
Questionnaire, and Behavior Sample) were designed to measure seven pre-linguistic
skills. These skills are organized into three composites: the Social composite, including
Emotion and Eye Gaze, Communication, and Gestures; the Speech composite, including
Sounds and Words; and the Symbolic composite, including Understanding and Object
Use (Wetherby et al., 2004).
The CSBS DP has been field-tested nationally, and the findings provide good
evidence for score reliability and validity and support the use of the Checklist as a firstlevel screening and the Behavior Sample as a second-level evaluation following the
Checklist (Wetherby & Prizant, 2002; Wetherby et al., 2002). The CSBS DP appears to
be effective for the early identification of young children with ASD as it measures prelinguistic skills that have been identified as deficits in preschoolers with ASD. Therefore,
the CSBS DP Checklist and Behavior Sample are appropriate screening and evaluation
tools for identifying children with developmental delays at 12 to 24 months of age
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(Wetherby et al., 2004). Use of a parent report tool, such as the Infant Toddler Checklist,
minimizes the time required of healthcare providers while maximizing the role of the
family. In addition, the Checklist provides reasonably accurate information regarding the
need to refer a child for a developmental evaluation (Filipek et al., 1999).
Autism-Specific Screening Instruments
Autism-specific screening instruments have been developed exclusively to screen
for autism spectrum disorders. In addition, most of these instruments have been designed
to concentrate on social and communication impairment in children aged 18 months and
older and focus on all three DSM-IV-TR criteria for autism. At this time, there is a lack
of highly score-validated autism-specific screening instruments available for children
under the age of 18 months. Autism-specific screening instruments that were discussed in
the ASC trainings include the Checklist for Autism in Toddlers (CHAT; Baron-Cohen,
Allen, & Gillberg, 1992), the Modified Checklist for Autism in Toddlers (M-CHAT;
Robins et al., 2001), and the Pervasive Developmental Disorder Screening Test (PDDST;
Siegel, 1998).
Checklist for Autism in Toddlers (CHAT). The Checklist for Autism in Toddlers
(CHAT) was developed by Baron-Cohen and colleagues in 1992. The CHAT was
developed in an effort to move toward earlier screening and identification of young
children, 18 months of age, at risk for autism spectrum disorders. The questionnaire
comprises two components; the first of which contains nine items reported by parents,
such as whether the child ever demonstrates pretend play. The second component
includes five items that require a brief, semi-structured observation by a primary care
provider at the well-child visit. These components assess parallel functioning in three
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main areas: (a) protodeclarative pointing, (b) gaze monitoring, and (c) pretend play. The
CHAT takes approximately 10 to 15 minutes to complete. If a child fails the CHAT, it is
recommended that the child be re-screened approximately one month later. If the child
fails the CHAT for a second time, the child should be referred to a specialist for further
evaluation as the CHAT is not a diagnostic tool.
The ease of administration and its demonstrated specificity to symptoms of autism
in children 18 months of age are two strengths of the CHAT (Filipek et al., 1999).
Findings from Baird et al.’s (2000) study demonstrated that the sensitivity for the CHAT
(number of children identified by the CHAT/number of children with autism in the entire
sample) was low (e.g., from 20%-35%). However, the specificity (number of children
without autism in the group who were not identified by the CHAT/number of children
without autism in the sample) was very high (e.g., from 98%-99.8%) (Scambler, Rogers,
& Wehner, 2001). Filipek et al. (1999) concluded that the CHAT appeared to be a useful
screening tool for identifying children 18 months of age at risk for autism. However, the
CHAT appears to be less sensitive to milder symptoms of autism, such as children with
Asperger syndrome or PDD-NOS (Filipek et al., 1999). Baron-Cohen et al. (1996) found
that the CHAT has a specificity of 98%, but a sensitivity of 38%, and missed many
children at 18 months who were later diagnosed with ASD. While the score validity of
the CHAT is disappointing, it indicates the need for further research on young children
with ASD and provides important clues to early indicators of ASD, based on the children
they were able to identify early (Baron-Cohen et al., 1996).
The Modified Checklist for Autism in Toddlers (M-CHAT). Robins, Fein, and
Barton (1999) developed the Modified Checklist for Autism in Toddlers (M-CHAT),
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which is an extension of the CHAT. The M-CHAT contains the nine parent-report items
from the CHAT, and additional items were developed based on symptoms thought to be
present in very young children with autism (Robins et al., 2001). The questionnaire
consists of 23 (yes/no) items reported by parents, in contrast to the combined parent
report and physician observation used in the CHAT. Because the M-CHAT is a parentonly screening instrument, the range of behaviors assessed is larger than on the CHAT
(Charman et al., 2001). Robins et al. suggest that the M-CHAT will have better
sensitivity at 24 months of age compared to 18 months of age.
Pervasive Developmental Disorder Screening Test (PDDST). Siegel (1998)
developed a parental questionnaire that consists of three stages, each targeting a different
level of screening to be used in different settings. The first stage is a parent questionnaire
aimed for use in primary care settings with children from birth to 36 months of age. The
PDDST rates both positive and negative symptoms, and contains a number of items
pertaining to regression. In addition, the PDDST examines temperament, sensory
responses, motor stereotypies, attention, attachment, and peer interest (Filipek et al.,
1999).
Summary
Unlike the CHAT or M-CHAT, the Infant-Toddler Checklist is not designed to
screen specifically for ASD, but rather, is designed as a first-level screen for children
with a broad array of communication delays. In regard to the Checklist, findings suggest
that children with ASD are likely to have low scores on the Social composite of the
Checklist and this pattern could be used to indicate the need to conduct an autism-specific
screen next, such as the CHAT or M-CHAT (Wetherby et al., 2004). However, there are
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not yet sufficient validity data on the CHAT, M-CHAT, or any other parent report tool to
support their use as a second-level screen for ASD in the second year of life, and
therefore, further research is needed.
Practice Parameters
Pediatric healthcare providers are typically involved in the identification of ASD
because they see young children on a regular basis at well-child visits, which occur quite
frequently throughout first two years of life (American Academy of Pediatrics [AAP],
2001). These well-child visits present numerous opportunities to identify children with
developmental delays or disabilities early in their development. Therefore, physicians can
play a key role in the early identification and subsequent early intervention of infants and
toddlers with ASD. Although the physician's role emphasizes the monitoring and
screening of the development of young children, limited information is available
regarding physicians' actual monitoring and screening practices (Filipek et al., 1999;
Sices, Feudtner, McLaughlin, Drotar, & Williams, 2003). Given the importance of early
identification and practitioners’ role in this process, it is problematic that less than 30%
of primary care providers conduct regular standardized screening tests at well-child
appointments (Dworkin, 1989).
The American Academy of Neurology and Child Neurology Society endorsed a
multidisciplinary consensus panel to review the literature on screening and diagnosis of
ASD and make recommendations on practice parameters (Filipek et al., 1999). The
consensus panel was developed from nominations from a variety of organizations related
to ASD, such as the American Academy of Child and Adolescent Psychiatry and the
American Academy of Pediatrics. The panel developed a number of recommendations for
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the screening and diagnosis of ASD, with two levels of investigation: (a) Routine
Developmental Surveillance and Screening Specifically for Autism, and (b) Diagnosis
and Evaluation of Autism (Filipek et al., 1999).
The first level consists of the following recommendations:
1. All professionals involved in early child care should be familiar with the symptoms of
ASD to recognize potential social, communicative, and behavioral indicators of the
need for further diagnostic evaluation.
2. Developmental screenings should be performed at every well-child visit, and at any
age thereafter if concerns are raised (recommended screening tools include ASQ,
PEDS, and BRIGANCE).
3. Failure to meet the nearly universally present developmental milestones (no babbling
by 12 months, no gesturing by 12 months, no single words by 16 months, no 2-word
spontaneous phrases by 24 months, any loss of any language or social skills at any age)
is an absolute indication to proceed with further evaluations.
4. Level 1 laboratory investigations, such as audiological assessments and lead screens
should be conducted.
5. Professionals should be familiar with and use one of the screening instruments for
children with autism (e.g., CHAT, PDDST).
6. The social, communication, and play development and behavior of siblings of children
with autism need to be carefully monitored.
7. As mandated by IDEA, a referral for early intervention should be initiated by the
primary care practitioner, with children under 36 months of age referred to zero-tothree service systems, and children 36 months of age and older referred to the local
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school district.
8. Healthcare providers need to increase their comfort levels in talking with families
about ASD.
9. Screening tools for older children with milder symptoms of ASD need to be available
in educational and recreational settings.
The second level of recommendations deals with diagnostic issues such as who
should make the diagnoses (e.g., professionals who specialize in the treatment of ASD),
the criteria on which the diagnoses should be based (e.g., DSM-IV-TR), and the level of
sensitivity and specificity that the diagnostic instrument should contain (Filipek et al.,
1999). The panel concluded that further research is required to identify more precise early
warning signs to differentiate accurately children with ASD from other populations.
Pediatric healthcare providers are in a key position to detect communication difficulties
in young children earlier on by conducting routine developmental surveillance on all
patients. The panel recommended that providers perform routine developmental
screenings for ASD at each well child visit using standardized instruments that utilize
parental report (Filipek et al., 1999).
In addition, the consensus panel suggested that failure to meet any of the
following five milestones is a definite indication for further evaluation: (a) no babbling
by 12 months, (b) no gesturing by 12 months, (c) no single words by 16 months, (d) no 2word spontaneous phrases by 24 months, and (e) any loss of any language or social skills
at any age. It is also important to monitor other social communication parameters, such as
deficits in joint attention and symbolic communication. Limitations in communication
development may be the first symptom evident to parents and professionals. The panel
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identified several early indicators that would necessitate further evaluation, including the
use of sounds, gestures, words, and word combinations. The panel stressed the
importance of recognizing that many of these symptoms also may be evident in children
with developmental disabilities who do not have ASD, or in children who are delayed,
but naturally catch up without intervention (Filipek et al., 1999).
Although the literature indicates that a number of primary care providers are not
routinely screening children for developmental disabilities during well-child
appointments, research findings suggest that pediatric healthcare providers are aware of
the important role that parental report and knowledge of developmental milestones can
have on the early identification of children with ASD (Sices et al., 2003). Sices et al.
(2003) found that most physicians reviewed developmental milestones and prompted
parents for developmental concerns at preventive care visits. However, only
approximately one-half of the physicians used a formal developmental screening
instrument. Although it is important for physicians to be aware of the possible usefulness
of parental report and knowledge of developmental milestones, it is also critical that
physicians are knowledgeable about both general developmental screening instruments
and autism-specific instruments. Moreover, it is essential that physicians utilize these
tools to enable them to identify children with ASD as early as possible (Sices et al.,
2003). However, primary referral sources are often unaware of early warning signs for
ASD and frequently take a “wait and see” attitude with parents, which contributes to the
delay in referral and subsequent identification, as well as a delay in initiating supports
and services (Oser & Shaw, 2001).
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A limited number of studies has examined physicians’ use of screening
instruments to identify young children with developmental delays (Sices et al., 2003).
Shonkoff, Dworkin, Leviton, and Levine (1979) examined primary care approaches to
developmental disabilities. The results revealed that only 19% of pediatricians reported
that their approach to a young child with a language delay would include the use of a
standardized developmental screening instrument. Furthermore, 38% of pediatricians
indicated that they would use a developmental screening instrument if parents raised a
concern about possible mental retardation in their 3-year-old child. Dobos, Dworkin, and
Bernstein (1994) conducted a similar study 15 years after the study by Shonkoff et al.
(1979). Dobos et al. found that 61% of pediatricians reported use of screening
instruments with children suspected of developmental delay (e.g., mental retardation).
The pediatricians from this study also were more likely to refer these children to be
assessed by specialists compared to the participants from Shonkoff et al.’s (1979)
investigation.
Although the use of score-validated screening tools is an effective way in which
physicians can identify children with developmental delays, research reveals that more
than one-half of children with developmental disabilities are not detected before school
entry. Furthermore, physicians often under-identify language-related delays and
disabilities in young children (Sices et al., 2003). Consistent use of developmental
screening tools could significantly improve physicians’ ability to detect children with
developmental delays. The use of formal instruments to obtain parental concerns, such as
the Parents' Evaluation of Developmental Status (PEDS), also could aid physicians in the
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early identification of delays and disabilities and guide the referral process (Sices et al.,
2003).
Sices et al. (2003) examined how primary care physicians identify young children
with developmental delays. A survey was mailed to a national random sample of
pediatricians and family physicians, with a total of 540 surveys returned (341 returned by
pediatricians and 199 returned by family physicians). Thus, the overall response rate for
the survey was 49.3%, which is similar to the average response rate to mail surveys (i.e.,
54%) for physicians (Asch, Jedrziewski, & Christakis, 1997). The survey inquired about
the methods used during the preventive care visits at 2 years of age to identify children
with developmental delays. Information regarding participants’ self-reports of current
developmental screening practices were obtained, and several hypotheses were tested
examining whether reported identification efforts varied depending on physician beliefs.
In addition, participants also were queried about factors that may influence their
developmental screening procedures. Five-point Likert-type scales were used to
determine the priority of developmental screening compared with other components of
the preventive care visit. In addition, physicians were asked to give their opinions about
seven statements concerning factors that might impact physicians' surveillance or
screening practices (Sices et al., 2003).
Findings from this study revealed that during routine preventive care visits with 2year-old children, most physicians reported using a list of developmental milestones as
well as the prompting of parents for specific concerns in multiple areas of the child's
development. One-half of the pediatricians and more than one-half of the family
physicians reported using some form of score-validated instrument for developmental
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screening. Approximately one-half of all the physicians reported that they used a specific
score-validated developmental screening instrument as part of their routine practices with
children ages 1 to 3 years. Finally, pediatricians and family physicians reported using a
similar group of available screening instruments (Sices et al., 2003). It is problematic that
even with the research support for early identification and screening practices, many
providers are not consistently screening all of their young patients during well-child visits
(Filipek et al., 1999). The following section details a number of potential factors that
could impede the routine screening of young children for developmental disorders such
as ASD.
Barriers to Pediatric Healthcare Providers’ Use of Screening Instruments
As noted earlier, given the research support for the benefits of early identification
and intervention, it is crucial that children are identified at as early an age as possible.
Although there is substantial evidence for symptom onset prior to 18 months of age,
many children with ASD are not diagnosed until six years of age (Filipek et al., 1999).
There are several hypotheses as to the reasons for the delay between presence of
symptomatology and diagnosis in children with ASD.
One hypothesis is that the primary referral sources, such as pediatric healthcare
providers, may be unfamiliar with the early warning signs of ASD, and therefore are
hesitant to refer these young patients for services. When practitioners are unfamiliar with
the warning signs of ASD, or are unfamiliar with the disorders in general, their selfefficacy in relation to identifying young children with ASD may be low. Perceived selfefficacy refers to a person’s beliefs about their ability to produce desired outcomes and
exercise control over events that affect their lives (Bandura, 1994). When people doubt
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their capabilities, they are more likely to shy away from difficult tasks that they view as
personal threats (Bandura, 1994). However, when self-efficacy is high, people approach
difficult tasks as challenges to be overcome rather than as threats to be avoided. In
addition, efficacious persons tend to become deeply engrossed in activities and set
challenging goals while maintaining a strong commitment to them (Bandura, 1994).
Therefore, it is crucial that practitioners feel confident and knowledgeable in their
abilities to screen and identify young children at-risk for ASD.
Another significant dilemma for healthcare providers is that identification must
precede the provision of services, and they may be hesitant to recommend a complete
evaluation for developmental disabilities for fear it will bring about anxiety in parents.
Furthermore, there is warranted concern regarding the emotional impact on the family
with the diagnosis of ASD, as some continue to hold the belief that ASD carries a poor
prognosis (AAP, 2001; Oser & Shaw, 2001). This apprehension could contribute to the
delayed identification of children with milder symptoms, as those with evident delays are
more likely to be identified earlier (AAP, 2001).
Recently, advances have been made in behavioral diagnostic criteria that have
lowered the potential age of diagnosis from around 5 years of age to as early as 18
months of age (Filipek et al., 1999). The consideration of additional behaviors not
previously thought to be diagnostic, such as motor behaviors, also have helped to lower
the potential age of diagnosis, with some research supporting accurate diagnosis at 8 to
12 months of age (Teitelbaum, Teitelbaum, Nye, Fryman, & Maurer, 1998).
The diagnostic features that are indicative of ASD typically develop throughout
the first two years of life; therefore, ASD should be evident in very young children.
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Based on retrospective accounts, most caregivers report that their children with ASD
displayed symptoms within the first two years of life (Wimpory, Hobson, Williams, &
Nash, 2000). Furthermore, most families express concern to their pediatrician by the time
their child is 18 months of age (Howlin & Moore, 1997). Although many children with
ASD are not diagnosed until at least three years of age, a diagnosis of ASD at two years
of age was found to be associated with the same diagnosis at three years of age or older in
the vast majority of children. Therefore, diagnoses of ASD in children two years of age is
as reliable (and consistent) as diagnoses made in children three years of age or older
(Lord, 1995; Stone et al., 1999). Children with ASD may not be identified during the first
two years of life because although some indicators of ASD commonly are present by two
years of age (e.g., impairments in social interaction and communication), others are not
evident until later. For example, restricted and repetitive activities and interests are
common indicators of ASD, yet these behaviors typically are not present until closer to 3
years of age. This delay in the onset of symptomatic behaviors could be a significant
factor in the later diagnosis of ASD in a majority of children (Wetherby et al., 2004).
Sices et al. (2003) also examined the barriers to the use of screening instruments
for physicians. Findings indicated that less than one-half of physicians agreed that there is
adequate time to perform developmental screening during a typical well-child visit.
Furthermore, very few agreed that reimbursement for well-child visits is sufficient to
cover the time spent on developmental screenings. Pediatricians reported feeling
confident in their care of a child diagnosed with a developmental delay more than twice
as often as family physicians. Pediatricians also were twice as likely as were family
physicians to agree that sufficient resources exist in their communities to address the
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needs of children with delays. Finally, pediatricians also were two times as likely as were
family physicians to report that they possess the clinical expertise to identify most
children with developmental delays without the use of a developmental screening
instrument (Sices et al., 2003).
In summary, findings from this study indicate that most physicians rely on lists of
developmental milestones and/or prompting for parental concern to identify children with
developmental delays. Physicians also reported time and reimbursement as significant
barriers to the use of screening instruments. The authors from this study concluded that
although the barriers to developmental screening in primary care are significant, most
physicians are aware of the value of early intervention services for young children with
developmental delays (Sices et al., 2003).
Halfon et al. (2001) also conducted a study to examine the barriers to the early
identification of developmental disabilities. In 2000, a survey was administered to
members of the American Academy of Pediatrics (AAP) to identify relevant barriers to
the timely identification of developmental issues in primary care practice. More
specifically, they sought to ascertain the barriers to the use of score-validated screening
instruments. In regards to children birth through 35 months of age, participants were
asked to describe the barriers to the provision of developmental assessments during
pediatric health supervision as a function of practice characteristics. Halfon et al. found
that 94% of the participants agreed that pediatricians should inquire about children’s
development. In addition, 80% of the participants felt confident in their ability to advise
parents; however, 65% reported less adequate training, and only 36% agreed that there
was adequate time for developmental assessments (Halfon et al., 2001).
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Insufficient time to administer screening instruments (80%) and reimbursement
issues (56%) were the most frequently cited barriers to utilizing formal developmental
screening instruments (Halfon et al., 2001). Participants also reported barriers such as
lack of available staff to assist with developmental assessments (51%), unfamiliarity with
coding for reimbursement (46%), lack of developmental diagnostic and treatment
services (34%), and lack of training (28%) (Halfon et al., 2001). Unfamiliarity with
screening instruments and lack of referral programs also were viewed by pediatricians as
significant barriers to the use of developmental screening instruments (Halfon et al.,
2001).
Although a number of barriers to the use of screening instruments were reported
by providers, there are ways in which these barriers can be overcome. Because
insufficient time to administer screening instruments was reported as the most significant
barrier to screening practices, it is important to note that score-validated parent
questionnaires may be used to minimize the time needed by providers to administer
screening instruments (Halfon et al., 2001). In addition, parental concern about a child's
development also may be a reliable predictor of developmental delays. It would be
beneficial to ascertain the extent to which primary healthcare providers are utilizing
parental report questionnaires for developmental screening. As Halfon et al. found, a
wide variation exists in the reported practice in the utilization of score-validated
screening instruments in primary care. Thus, future research needs to be conducted on the
early identification of children with developmental delays.
In the survey conducted by Halfon et al. (2001), approximately one-half of the
physicians reported that they use a score-validated developmental screening instrument in
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their practices. However, although physicians report that they are using a variety of
methods to identify children with delays, a significant number rely only on lists of
developmental milestones or prompting for parental concern. In addition, because
providers do not have adequate time to administer screening instruments, when they are
utilized it is likely that they are not used in a standardized manner, which diminishes their
score validity (Halfon et al., 2001). The increased use of parent questionnaires that yield
valid scores (e.g., ASQ, PEDS) will ameliorate the time constraint providers’ face, which
is a significant barrier to their use of screening instruments. Additionally, as providers
continue to cite reimbursement as a central barrier to the utilization of developmental
screening instruments, this issue needs to be addressed at a policy level (Halfon et al.,
2001).
Importance of Training for Providers in Identifying Children with ASD
The American Academy of Pediatrics (AAP) developed practice guidelines that
recommend routine developmental screening and surveillance to be conducted
specifically for autism on all children. Routine developmental screening first would
identify children at risk for any type of atypical development, and also would identify
those specifically at risk for autism (AAP, 2001). However, a number of healthcare
providers do not feel comfortable utilizing developmental screening instruments because
of a lack of training. In addition, they may not know how to implement these guidelines
successfully to perform accurate developmental screenings with young patients (Halfon
et al., 2001). Therefore, healthcare providers would benefit from specific guidance on
how to incorporate routine developmental screenings into their practices because a lack
of guidance may result in the delay of identification and appropriate intervention services
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(AAP, 2001). When children with developmental delays or disabilities are identified and
receive treatment early, the negative impact on the functioning of both the children and
the families may be greatly reduced.
It is critical that trainings address the barriers that prevent healthcare providers
from routinely using developmental screening instruments with their patients, such as
time constraints and reimbursement issues. There are continuing efforts to increase
awareness of ASD in practitioners, including knowledge of developmental milestones,
warning signs for development that is not following expected trajectories, and scorevalidated screening instruments (Oser & Shaw, 2001). Because of the importance of
receiving appropriate training to identify young children with developmental disabilities,
it is problematic that the majority of pediatric healthcare providers are not routinely using
developmental screening tools.
Halfon et al. (2001) found that family physicians reported substantially lower selfefficacy to support children with developmental delays/disabilities compared to
pediatricians. In addition, family physicians also perceived community resources as being
less available to support these children compared to reports from pediatricians. These
findings underline the importance of providing all healthcare providers who work with
children specific educational interventions. These specific interventions should be
tailored to improving confidence in managing children with developmental
delays/disabilities, as well as increasing their awareness of available community
resources. Furthermore, interventions also could help to improve the availability of
resources within some communities (Halfon et al., 2001).
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Summary
Autism is a neurodevelopmental disability that affects the functioning of the brain
and typically appears during the first three years of life. The primary features of autism
are the presence of abnormal or impaired development in communication and social
interaction, and a restricted repertoire of behaviors and interests. Because the etiology of
autism spectrum disorders (ASD) is unknown, interventions for individuals with ASD are
developed to reduce the interfering symptoms. Given the recent increases in the number
of children diagnosed with ASD, it is crucial that children are identified early on so that
they receive the services needed (Filipek et al., 1999; Oser & Shaw, 2001).
Growing evidence demonstrates the effectiveness of intensive early intervention
with a significant proportion of young children with ASD (Dawson & Osterling, 1997;
Filipek et al., 2000; Oser & Shaw, 2001). Dawson et al. (2000) found that as the prenatal
and early postnatal years represent a sensitive period for brain and behavioral
development, increased efforts at early identification and intervention are needed.
Negative consequences for individuals with ASD can be minimized or avoided
completely with the promotion of optimal prenatal and infant-toddler development, as
long-term consequences have their greatest influence during early child development.
It is recommended by the American Academy of Pediatrics (AAP) that all infants
and children are screened for developmental delays or disabilities (AAP, 2001). The
National Research Council Report on Educating Children with Autism (2001) reviewed
several screening instruments for the detection of ASD. The Checklist for Autism in
Toddlers (CHAT) has been score validated, and the Modified Checklist for Autism in
Toddlers (M-CHAT), the Ages and Stages Questionnaire (ASQ), and the Pervasive
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Developmental Disorders Screening Test (PDDST) currently are in the process of being
score validated. In addition, NECTAS reported that developmental screening instruments,
such as the Parents’ Evaluation of Developmental Status (PEDS), can accurately provide
information about children’s development. Greater public awareness and education of
healthcare providers in regard to the early detection of developmental disorders and how
to access appropriate interventions are needed. Providers need to be proficient in the
identification of early symptoms of autism so that appropriate screening and referral
procedures can occur.
The NECTAS Forum on ASD discussed strategies for earlier identification,
including raising public and professional awareness, tools for screening, determining
eligibility for services, and transitioning. The early identification of children with
developmental disabilities requires that healthcare providers are familiar with scorevalidated screening instruments. It is also critical that they feel comfortable discussing
parental concerns, and that they are knowledgeable about referral resources in their
communities (AAP, 2001). Although the physician's role emphasizes the screening of the
development of young children, limited data are available regarding physicians' actual
monitoring and screening practices (Filipek et al., 1999; Sices, Feudtner, McLaughlin,
Drotar, & Williams, 2003). It is problematic that less than 30% of primary care providers
conduct regular standardized screening tests at well-child appointments, given the
importance of early identification and healthcare providers’ role in this process (Dworkin,
1989).
The American Academy of Pediatrics (AAP) developed practice guidelines that
recommend routine developmental screening and surveillance to be conducted
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specifically for autism on all children. Routine developmental screening first would
identify children at risk for any type of atypical development, and also would identify
those specifically at risk for autism (AAP, 2001). However, a number of healthcare
providers do not feel comfortable utilizing developmental screening instruments because
of a lack of training. In addition, they may not know how to implement these guidelines
successfully to perform accurate developmental screenings with young patients (Halfon
et al., 2001). Healthcare providers would benefit from guidance on how to incorporate
routine developmental screenings into their practices because a lack of guidance may
result in the delay of identification and appropriate intervention services (AAP, 2001).
When children with developmental delays or disabilities are identified and receive
treatment early, the negative impact on the functioning of both the children and the
families may be greatly reduced. Future research is needed to examine the effectiveness
of trainings for healthcare providers regarding screening practices and early identification
of ASD.
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Chapter 3
Method
Participants
The participants in this study were pediatric healthcare providers who practiced
medicine and resided in the state of Florida. Selected participants attended one of three
field-test training sessions held throughout Florida. The number of pediatricians currently
practicing in the state of Florida is approximately 3,423 (American Academy of
Pediatrics [AAP], 2000). All geographic locations throughout Florida were considered for
the settings of the training, with the expectation that each of the three training sessions
would be held in three different geographic areas, with at least one location defined as
rural, and at least one location defined as urban. The participants were recruited to
participate in the training sessions from the following geographic regions: Clewiston,
Jacksonville, and Tampa, Florida. These geographic areas were selected because of
availability and interest in the ASC training in these locations. More specifically, the first
training session was held on Wednesday, May 4, 2005 at the University of South Florida,
Florida Mental Health Institute from 6:00 p.m. to 7:00 p.m. The second training session
was held on Wednesday, May 18, 2005 at the Duval County Health Department from
3:00 p.m. to 4:00 p.m. The third training session was held on Wednesday, June 1, 2005 at
the Hendry Regional Medical Center from 12:00 p.m. to 1:00 p.m. A fourth training
session at the University of South Florida, Florida Mental Health Institute was added in
an attempt to obtain more participants to complete the ASC training. Unfortunately, no
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participants took part in this last training session. The criteria for participation in the ASC
training session were: (a) residence in the state of Florida and (b) provision of services to
the pediatric population. Therefore, variability in age, gender, race, geographic location,
profession, setting of practice, years in practice, and number of trainings completed
related to ASD was expected.
Selection of Participants
Participants were selected based on their professional roles and the geographic
location where they practiced medicine. One major goal of this training focused on
reducing barriers to screening by problem solving ways in which to change practice;
therefore, the main aim was to recruit pediatricians and pediatric nurse practitioners
because they are most likely to be in the position to facilitate change within their
practices. Furthermore, the primary interest of this study was in the screening practices of
physicians because research demonstrates that the majority of physicians (i.e., 86%)
indicate they are predominantly responsible for developmental screening and/or
surveillance (Sices et al., 2003). However, registered nurses and other pediatric
healthcare professionals also were recruited for participation in the ASC training.
Prior to the recruitment of any participants, approval for this study was obtained
from the University of South Florida Institutional Review Board (IRB) to ensure the
ethical treatment of the participants in this study. Pediatric healthcare providers were
recruited to participate in the ASC training by contacting department chairs in the
division of pediatrics via telephone. In addition, three flyers detailing the learning
objectives of the training sessions were developed by the ASC workgroup (see Appendix
A). These flyers were electronically mailed to the workgroup for dissemination to
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practitioners via email. For the first training, flyers also were posted on the University of
South Florida campus. Additionally, workgroup members distributed the flyers at the
Hillsborough County Pediatrics Society (HCPS) Meeting on April 20, 2005, and the
HCPS meeting on April 21, 2005. For the second training, flyers were disseminated by a
pediatrician who practices medicine in Jacksonville, Florida. For the third training, flyers
were disseminated both via electronic mailings and postings at the Hendry Regional
Medical Center and the Hendry County Health Department in Clewiston, Florida.
Physicians who participated in the ASC training received one Continuing Medical
Education (CME) credit, and nurse practitioners who participated received one
Continuing Education Unit (CEU).
The pediatric healthcare providers were invited to participate in one of the three
ASC trainings based on location. The original goal was to train a minimum of 100
pediatric healthcare providers throughout the state of Florida, as stipulated by the grant
that funded the ASC trainings. Unfortunately, this goal was not obtained because only 36
practitioners completed the ASC training. To obtain a statistical power of .80 for
detecting a medium effect size for comparing the two experimental locations at the .05
level of significance, using a repeated measures analysis of variance (ANOVA), a
minimum of 40 participants was needed (Cohen, 1988). Practitioners who agreed to
participate in the ASC training were placed in one of two experimental groups based on
their geographic location (i.e., rural or urban). It was hoped that there would be
approximately the same number of participants who attended each of the three training
sessions and who participated in the study. Pre- and post-test analyses were conducted to
determine if there were statistically significant differences among the three training
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groups and whether any of the groups could be collapsed. All training participants were
invited to participate in this study, with the expectation that virtually all participants in
the trainings would complete the pre-test questionnaire. However, it was expected that
approximately 50 participants would complete both the pre- and post-questionnaire
because research demonstrates the average response rate to mail surveys for physicians is
54% (Asch et al., 1997).
Practitioners in the state of Florida who had not participated in the ASC trainings
were asked to take part in the control group. These pediatric healthcare providers were
contacted via mailings to their places of employment describing the goals and purpose of
the study. These participants met the same criteria of the participants in the experimental
group (e.g., practicing medicine in the state of Florida, and working with the pediatric
population). The researcher attempted to contact approximately 50 providers, with the
goal of obtaining a minimum of 25 participants for the control group. Attempts were
made to recruit participants for the control group from the same three geographic regions
as participants in the experimental group. Questionnaires were mailed multiple times, as
necessary, to attain at least 25 participants in the control group to ensure that the sample
size was large enough to obtain adequate statistical power.
The sampling scheme used for this study represented non-random, convenience
sampling. The participants were arranged into one of three groups based on geographic
location and participation in the ASC training. The groups were as follows: (a) ruralexperimental group, (b) rural-control group, (c) urban-experimental group. Participants in
the control group were recruited from a region in central Florida. Because the participants
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were assigned to training groups based on their geographic location and participation in
the ASC trainings, they were not randomly assigned to the three groups.
Research Design
This study utilized a quasi-experimental research design. Specifically, the type of
quasi-experimental design was a pretest-posttest nonequivalent-groups design (Best &
Kahn, 2003). Quasi-experimental designs provide the researcher control of when and to
whom the measurement is applied; however, participants were not randomly assigned to
experimental and control treatments. Therefore, the equivalence of the groups could not
be assured (Best & Kahn). The pretest-posttest nonequivalent-groups design is commonly
used when experimental and control groups are naturally assembled groups (Best &
Kahn). This design was used because it was the most feasible design for this study. The
researcher did not have any influence over the assignments of participants to the
experimental group and the control group; therefore, similarity across groups with respect
to important characteristics, such as knowledge of ASD or use of screening instruments
could not be controlled.
Variables
Several dependent and independent variables were measured in this study. The
dependent variables were the strength of barriers pre- and post- training, screening tools
utilized (both general and autism-specific), perceived levels of general knowledge related
to ASD, and self-efficacy of participants in relation to accurate screening practices. The
independent variable in this study was the type of training: Autism System of Care
training (i.e., experimental group) versus no training (i.e., control group).
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Instrument
Pediatric Healthcare Provider Self-Report Questionnaire
The Pediatric Healthcare Provider Self-Report Questionnaire was developed by
the principal investigator for the purpose of this study. This measure was designed to
assess the effect of the Autism System of Care training on pediatric healthcare providers’
change in practice regarding the method of ASD early identification. The questionnaire
contains a total of four sections: (a) general knowledge of Autism Spectrum Disorders,
(b) use of screening instruments, (c) perceived barriers to utilization of screening
instruments, and (d) demographic information. The first three sections of the
questionnaire were covered in the ASC trainings.
The first section of the Pediatric Healthcare Provider Self-Report Questionnaire,
entitled “General Information,” contains a total of six items. The first four items in this
section assess perceived levels of knowledge of ASD, such as knowledge of autismspecific screening instruments and knowledge of early warning signs of ASD. These
items utilize a four-point rating scale (1 = Poor, 2 = Fair, 3 = Good, 4 = Excellent),
asking participants to rate their levels of knowledge by circling the most appropriate
number that corresponds with their perceived levels of knowledge. An example of an
item is, “How would you assess your overall knowledge of early warning signs of ASD?”
The scale used for this section is the Perceived Knowledge Scale, which is divided into
two parts. The first part contains four items utilizing a four-point rating scale (i.e., 1 =
Poor, 2 = Fair, 3 = Good, 4 = Excellent). The response for each item is summed to
generate a total scale score. The scores range from 4 to 16, with high scores indicating the
participant perceives herself/himself to have excellent knowledge related to ASD. The
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last two items in this section assess participants’ self-efficacy regarding their ability to
screen and refer children suspected of having an ASD. The format of the last two items is
open-ended, with participants asked to indicate the age, in months, at which they believe
children can be accurately screened and referred for Autism Spectrum Disorders, and the
age at which they believe they themselves can accurately screen and refer children
suspected of having Autism Spectrum Disorders.
The second section, entitled “Screening Patterns,” contains three subsections
related to use of screening instruments. The screening instruments included in the
questionnaire are the same instruments that were chosen for review in the ASC training
sessions. These instruments were selected for the training sessions based upon two
factors known to impact their use: (a) time to administer the instrument and (b) cost of
the instrument (Halfon et al., 2001). For all three subsections, participants were asked to
indicate on a five-point rating scale (1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Usually,
5 = Always) how often they use each individual screening tool, and how often they use
developmental screening tools with patients in different age groups.
Subsection A contains items regarding participants’ use of three general
developmental screening instruments, including the Ages & Stages Questionnaire (ASQ),
Parent’s Evaluation of Developmental Status (PEDS), and Communication and Symbolic
Behavior Scales Developmental Profile: Infant-Toddler Checklist (CSBS DP).
Subsection B has items regarding use of the following three autism-specific screening
instruments: the Checklist for Autism in Toddlers (CHAT), the Modified Checklist for
Autism in Toddlers (M-CHAT), and the Pervasive Developmental Disorder Screening
Test (PDDST). The Screening Scale corresponds with Subsections A and B in the second
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section (i.e., Screening Patterns). The developmental subscale consists of three items
utilizing a five-point rating scale (i.e., 1 = Never, 2 = Rarely, 3 = Sometimes, 4 =
Usually, 5 = Always). The response for each item is summed to generate a total subscore.
The scores for this subscale range from 3 to 15, with high scores indicating frequent use
of developmental screening instruments. The autism-specific subscale contains three
items utilizing the same five-point rating scale as the developmental subscale. The scores
from this subscale also range from 3 to 15, with high scores indicating frequent use of
autism-specific screening instruments. The total screening scale (i.e., developmental scale
and autism-specific scale) ranges from 6 to 30.
Subsection C contains items regarding how often participants use developmental
screening instruments in relation to seven age ranges of patients. Ages were grouped in
either 6- or 12-month increments, based on the recommended ages for well-child visits
(e.g., 0-6 months, 7-12 months, 13-18 months, 19-24 months, 25-36 months, 37-48
months, and older than 48 months) (AAP, 2001). The Age of Screening Scale
corresponds with Subsection C from the Screening Patterns section, and each item from
this scale was assessed individually.
The third section of the instrument assesses the perceived impact of potential
barriers on participants’ use of screening instruments. Potential barriers were developed
by reviewing the literature on barriers related to the use of developmental screening
instruments and the referral of patients suspected of ASD for further evaluation.
Participants were asked to indicate on a four-point Likert-type scale (1 = Unlikely, 2 =
Somewhat Unlikely, 3 = Somewhat Likely, 4 = Very Likely) the extent to which specific
barriers (n = 7) were likely to impact their ability to screen or refer patients for further
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evaluation. An example of an item in this section is, “Insufficient information regarding
referral resources.” The Barriers Scale is the fourth scale on the questionnaire. The
responses were summed to yield a total scale score. Scores from this scale range from 7
to 28, with high scores indicating the potential barriers are very likely to impede use of
screening instruments.
The fourth and final section of the questionnaire contains nine items that elicit
demographic information. The following information was gleaned: (a) age, (b) gender,
(c) race, (d) location of practice, (e) profession, (f) setting of practice, (g) years in
practice, (h) number of trainings completed related to Autism Spectrum Disorders, and (i)
number of trainings completed related to changing practice/service delivery. For number
of years in practice, and number of trainings completed related to both ASD and
changing practice/service delivery, participants were asked to write in the appropriate
number. For all other demographic items, multiple-choice options were provided (e.g.,
for race: White [Non-Hispanic], Black/African American, Hispanic, Asian/Pacific
Islander, Native American, Multi-Racial/Ethnic, Other). The Pediatric Healthcare
Provider Self-Report Questionnaire is presented in Appendix B.
The Pediatric Healthcare Provider Self-Report Questionnaire was reviewed by an
expert panel to assess its content-related validity. The panel comprised group members
who developed the ASC trainings (n = 6), including pediatricians (n = 3), professors from
related fields (n = 2), and the director of an autism center in the region (n = 1). No
members from the expert panel participated in this study. Copies of the questionnaire
were distributed to the expert panel to obtain feedback on each of the items. The
researcher conducted semi-structured interviews with members of the expert panel to
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review the items on the questionnaire. The panel believed that the first draft of the
questionnaire was too long with 47 items, and as a result, participants might be less likely
to complete the questionnaires. Therefore, the panel recommended removing 12 items
from the questionnaire that were not as strongly related to the content of the ASC
trainings as the remaining items. The panel also suggested reducing the length of the
questionnaire so that the 35 items fit onto two pages. These changes were made, and the
final version of the copy was distributed to the panel and was subsequently approved by
all panel members.
The questionnaire was completed both prior to and approximately two to three
months after completion of the training session. This time frame was chosen after
discussion with several pediatricians from the expert panel. It was agreed among the
panel members that two to three months was an appropriate time period to measure
change in screening practices for pediatric healthcare providers. Approximately one week
following the initial mailing of the post-test questionnaire, a follow-up postcard was sent
to participants to remind them to complete and return the post-test questionnaire.
Approximately two weeks following the reminder postcard, the post-test questionnaire
was resent to all participants who had not returned the completed post-test questionnaire.
Two weeks after the second mailing of the post-test questionnaire, a final reminder
postcard was sent to participants who had not returned the completed post-test
questionnaire.
Procedures
The procedures for this study included the researcher identifying the content to be
disseminated in the Autism System of Care trainings, developing the Pediatric Healthcare
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Provider Self-Report Questionnaire based on the content of the trainings, and obtaining
approval from the Institutional Review Board. After the training materials were
developed and finalized by the ASC group members, the researcher developed the
questionnaire based on the content that was to be included in the Autism System of Care
training sessions.
The Autism System of Care training was developed from a one year extension
grant that was funded by the Florida Developmental Disabilities Council. The previous
grant (i.e., year one) surveyed pediatricians throughout Florida, and based on the results
of the survey responses, it was determined that a need existed in Florida to provide more
information about early screening and referring for ASD. The Autism System of Care
training sessions were one hour in length, and were structured as workshops for the
participants. The locations of the training sessions were: (a) Clewiston, FL, (b)
Jacksonville, FL, and (c) Tampa, FL. Two pediatricians involved in the development of
the ASC training facilitated the training sessions. One of the presenters is a
developmental pediatrician who practices medicine in Pinellas County, Florida. The other
presenter is a general pediatrician who practices medicine in Duval County, Florida. Both
physicians had considerable knowledge related to ASD and the importance of early
identification. The goal of the training was to improve pediatric healthcare providers’
screening practices for the early identification of children with ASD. Therefore, the
sessions included a brief overview of ASD (e.g., definition, areas of impairment, and
etiology), a review of the warning signs of ASD, and a review of common screening
instruments. In addition, a discussion regarding the importance of early screening and
identification and the barriers to routine screening practices occurred. Finally, a model for
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improving screening practices was discussed, and participants were asked to create aim
statements for changing their practices and develop the next steps to initiate these
changes. The presenters utilized a PowerPoint presentation to ensure that the same
material was presented to all participants in the three training sessions. Each session
included a PowerPoint presentation and individual and small group activities related to
the material in the presentation. In addition, participants received handouts containing the
slides from the presentation, as well as handouts containing additional information
regarding screening instruments. To ensure that all learner objectives were covered in
each of the training sessions, an implementation checklist was developed by the
researcher (see Appendix C). The implementation checklist contained 27 items directly
from the PowerPoint presentation. The researcher indicated the extent to which each item
was covered by placing a checkmark in either the “Yes,” “Partially,” or “No” column.
In regard to the questionnaires, arbitrary identification numbers created by the
researcher were included on the actual questionnaire forms to ensure anonymity. A cover
sheet was attached to each questionnaire (i.e., pre- and post-test questionnaires) detailing
the purpose of the study and expressing gratitude for participation in the study. In
addition, the cover sheet included information regarding an incentive for completing and
returning the post-test questionnaire. When a post-test questionnaire was returned, the
identification number on the questionnaire was entered into a drawing. There were two
$25 gift certificates awarded; one to a participant who completed the ASC training and
one to a participant from the control group. Participants were asked to include their
names and email addresses on the bottom of the pre-test cover letter to receive summaries
of individual and/or overall results from the study. The email addresses also were used to
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contact the two winners from the drawings. Participants were asked to provide their
names on the cover sheets for the pre-test questionnaire only. The cover sheets attached
to the post-test questionnaires did not require participants to provide their names.
Each questionnaire cover sheet contained a unique identification number and was
attached to a questionnaire with the corresponding identification number. The cover
sheets attached to the pre-test questionnaires subsequently was detached by the researcher
to separate identifying information (i.e., names) from the completed questionnaires. The
identification numbers on the pre-test questionnaire cover sheets were used to match
participants’ names to the corresponding pre-test questionnaires. The post-test
questionnaire utilized the same identification number as the pre-test questionnaire for
each individual participant.
A sign-in sheet was posted at each training session. When participants arrived for
the trainings, they were asked to sign in and provide their current mailing addresses.
Immediately prior to the training session, the researcher distributed the pre-test
questionnaires to the participants and collected the completed questionnaires and cover
sheets before the start of the session. A master list of participants was created to match
each participant’s name with his/her unique identification number and corresponding pretest questionnaire. The post-test questionnaires, along with a return addressed, stamped
envelope, were mailed to the participants approximately 8 to 12 weeks after completion
of the training. These questionnaires contained only the unique identification numbers
printed on the cover sheets and questionnaires. Therefore, the participants were able to
return the post-test questionnaires without any identifying information.

58

The researcher matched the post-test questionnaires’ identification numbers with
the corresponding pre-test questionnaires’ identification numbers. Once the pre- and posttest questionnaires were matched, all identifying information was removed and discarded.
All data obtained from the questionnaires were accessible only to the researcher and were
stored in a locked file cabinet. The control group completed the questionnaire twice,
during the same time period as the experimental groups. That is, the control group
completed the first copy of the questionnaire (pre-test) sometime between April and May
of 2005, which was the time period for the three ASC training sessions. Participants in
the experimental groups and the control group completed the post-test in July or August
of 2005. Once all questionnaires were returned, the researcher conducted analyses,
interpreted the results, and presented the findings.
Analyses
Pre-Test Analyses
Once all pre-test questionnaires were completed by the participants and returned
to the researcher, the data were analyzed. Descriptive statistics were computed for both
pre- and post-test data pertaining to all of the scales. In addition, descriptive statistics
were computed for the participants’ demographic information. Next, an exploratory
factor analysis was conducted to examine the construct-related validity of scale scores,
and to reduce the number of items within each scale by grouping items that were
moderately to highly correlated with one another (Fraenkel & Wallen, 2003). For each
scale and subscale that emerged from the factor analysis, score reliability coefficients
were computed using Cronbach’s alpha for each treatment group (i.e., control and
experimental groups) and as a whole (Glass & Hopkins, 1996).
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To assess regional differences in responses at pre-test, a series of independent
samples t-tests was used to compare participants from the rural areas and those from
urban areas across the subscales that comprised the three main sections of the
questionnaire (e.g., perceived levels of knowledge and self-efficacy, screening practices,
and perceived barriers). The urban and rural groups were not differentiated if no
statistically significant differences emerged. In addition, to examine pre-existing
differences between treatment groups, a series of independent samples t-tests was used to
compare participants from the experimental group and those from the control group
across the subscales that comprised the three main sections of the questionnaire. If no
statistically significant different emerged between the experimental and control groups,
then it was assumed that the experimental groups and control groups did not differ on the
outcome variables prior to the intervention.
To determine the relationship between pediatric healthcare providers’ perceived
barriers to utilizing screening instruments and their actual use of screening instruments
before completion of the ASC training, a Spearman rank correlation coefficient was
conducted on the pre-test measures. A 5% level of significance was used to test this
relationship. An effect size was interpreted if statistical significance was found. Cohen’s
(1988) criteria were used to interpret effect sizes (i.e., .1 = small, .3 = medium, .5 =
large).
Post-Test Analyses
The following research questions were addressed in this study:
Research question 1. What is the effect of the Autism System of Care (ASC)
training on use of developmental and autism-specific screening instruments by pediatric
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healthcare providers? To address this question, a 2 X 2 repeated-measures ANOVA was
conducted. The repeated-measures ANOVA was conducted to determine if there was a
statistically significant difference in outcomes between the experimental group and
control group. In addition, the results from the repeated-measures ANOVA indicated
whether there was a statistically significant difference in outcomes between the two time
points (i.e., pre-test and post-test), as well as if there was a statistically significant
interaction between group and time (Maxwell & Delaney, 1990). The repeated-measures
ANOVA, also called a split-plot design, is especially valuable for comparing groups
across time longitudinally (Maxwell & Delaney, 1990). The between-subjects factor in
this analysis was group (i.e., experimental group vs. control group). The within-subjects
factor was time (i.e., pre-test and post-test). Because two outcomes (i.e., dependent
measures) were of interest, namely, use of developmental screening instruments (Range =
3 to 15), and use of autism-specific screening instruments (Range = 3 to 15) two sets of 2
X 2 repeated-measures ANOVA were conducted.
Research question 2. What is the effect of the ASC training on the use of
developmental screening instruments in regards to age of patient? To address this
question, Wilcoxon’s signed rank test was undertaken. A 5% level of significance (i.e.,
alpha level of .05) was used (Glass & Hopkins, 1996). Bonferroni’s adjustment was used
to keep alpha level of significance at 5% (Glass & Hopkins, 1996).
Research question 3. What is the effect of the Autism System of Care training on
pediatric healthcare providers’ perceived barriers to increasing the use of screening
instruments and/or referring patients? Two sets of 2 X 2 repeated-measures ANOVA
were conducted to address this question. The between-subjects factor in this design was
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group (i.e., experimental group vs. control group) and perceived levels of barriers were
the dependent variables, whose pre- and post-measures served as the within-subjects
factor.
Research question 4. What is the effect of the Autism System of Care training on
pediatric healthcare providers’ perceived levels of knowledge related to Autism Spectrum
Disorders? A 2 X 2 repeated-measures ANOVA was conducted to address this research
question. The between-subjects factor was group (i.e., experimental group vs. control
group) and perceived levels of knowledge were the dependent variables, whose pre- and
post-measures served as the within-subjects factor.
Research question 5. What is the effect of the Autism System of Care training on
the self-efficacy of pediatric healthcare providers regarding the ability accurately to
screen and refer a child suspected of having an Autism Spectrum Disorder? Two separate
2 X 2 repeated-measures ANOVAs were conducted to address the fourth research
question. The between-subjects factor was group (i.e., experimental group vs. control
group) and perceived levels of self-efficacy of participants were the dependent variables,
whose pre- and post-measures served as the within-subjects factor.
Research question 6. What is the relationship between pediatric healthcare
providers’ perceived barriers to utilizing screening instruments and their actual use of
developmental and autism-specific screening instruments before and after completion of
the training? To address this research question, two Spearman rank (order) correlation
coefficients were conducted (i.e., for pre- and post-test scores) to determine the degree of
relationship between each pair of scores (Fraenkel & Wallen, 2003). The independent
variables were level of perceived barriers, and the dependent variables were (a) use of
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developmental screening instruments (Range = 3 to 15), and (b) use of autism-specific
screening instruments (Range = 3 to 15).
Research question 7. What is the relationship between perceived barriers to
utilizing screening instruments and the use of developmental screening instruments in
regard to age of patients before and after completion of the training? To address this
research question, a series of Spearman rank correlation coefficients was computed for
both pre- and post-test scores. The independent variable was level of perceived barriers
and the (seven) dependent variables were the frequency of use of developmental
screening instruments in regard to seven age ranges of children. The Bonferroni
adjustment was used to control for the inflation of Type I error. Specifically, a
Bonferroni-adjusted alpha value of .007 (i.e., .05/7) was used to reflect the fact that seven
correlations were computed.
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Chapter 4
Results
Treatment of the Data
The data were entered into an Excel spreadsheet by the researcher and another
school psychology graduate student following the completion of both the pre-test and
post-test questionnaires. Each score was entered for every participant on each individual
item. Missing data were coded as a blank space in the Excel document. The researcher
and another school psychology graduate student checked the data by randomly selecting
participants’ identification numbers and matching the data in the database to the entrees
completed by hand by the randomly selected participant. Additionally, extreme values
were checked across each participant for each item to ensure that the data were entered
correctly. Inter-rater reliability was 100%.
Missing Data Analysis
At pre-test a total of 49 pediatric healthcare providers participated, comprising 25
in the experimental group and 24 in the control group. At post-test a total of 26 pediatric
healthcare providers participated, consisting of 13 in the experimental group and 13 in the
control group. This represented an overall completion rate of 53.1%, a completion rate of
52% for the experimental group and 54.2% for the control group.
Of those who completed the study, only one item was not completed by one
person in the experimental group (i.e., item asking to indicate the age at which they
believe they are able to screen a child suspected of having an ASD). For the control
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group, every item was completed by all participants. For the repeated measures analysis
of variance (ANOVA), a sample size of 40 was needed to detect a statistically significant
difference between the experimental and control group with a power coefficient of .80 at
the 5% level of significance. Because the post-test sample size was 26 the statistical
power for the repeated measures ANOVA was below the desired level. The power also
was low for the correlation analyses (i.e., Spearman rank).
Pre-Test Analyses
After all data were transferred from the Excel spreadsheet into an SPSS data
editor file, the data were analyzed. Descriptive statistics were computed for both pre- and
post-test data (see Table 1). In addition, descriptive statistics were computed for the
participants’ demographic information (see Table 2). Next, a series of exploratory factor
analyses was conducted to examine the underlying structure of the items within each
section and to reduce the dimensionality of the items within each section by grouping
items that were moderately to highly correlated with one another (Fraenkel & Wallen,
2003).
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Table 1
Descriptive Statistics for Pre-Test and Post-Test Data

Variable
Age
<30
31-40
41-50
51-60
>60
Gender
Male
Female
Race
White (NonHispanic)
Black/African
American
Hispanic
Asian/Pacific
Islander
Native American
Multi-Racial/Ethnic
Other
Location of Practice
Rural
Suburban
Urban
Other
Profession
Pediatrician
Family Practice
Registered Nurse
Nurse Practitioner
Other
Setting of Practice
Hospital
Clinic
Private Practice
UniversityAffiliated Center
Other
* p < .05

Pre-Test Only
(n = 23)
(%)

Pre-Test and Post-Test
(n = 26)
(%)

21.7
26.1
26.1
13.0
13.0

23.1
26.9
30.8
19.2
0.0

Chi Square (df)
3.78 (4)

2.37 (1)
39.1
60.9

19.2
80.8

69.6

80.8

8.7
8.7
4.3

3.8
11.5
3.8

0.0
4.3
4.3

0.0
0.0
0.0

34.8
34.8
30.4
0.0

19.2
26.9
53.8
0.0

69.6
4.3
4.3
8.7
13.0

73.1
3.8
0.0
23.1
0.0

21.7
26.1
17.4

19.2
34.6
15.4

17.4
17.4

30.8
0.0

3.04 (5)

2.92 (2)

6.10 (4)

5.77 (4)
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Table 1 (Continued)
Descriptive Statistics for Pre-Test and Post-Test Data

Variable
Years in Practice
1-10
11-20
21-30
31-40
ASD Trainings
0
1-3
4-5
Change in Practice
Trainings
0
1-3
4-7
* p < .05

Pre-Test Only
(%)
(n = 23)

Pre-Test and PostTest
(%)
(n = 26)

56.3
17.4
17.3
8.6

Chi Square (df)
19.72 (20)

61.4
22.9
11.4
3.8
7.22 (6)

45.5
36.3
13.6

64.0
36.0
0.0

73.7
21.1
5.3

75.0
25.0
0.0

2.28 (4)
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Table 2
Demographic Characteristics of Experimental and Control Groups at Pre-Test

Variable
Age
<30
31-40
41-50
51-60
>60
Gender
Male
Female
Race
White (Non-Hispanic)
Black/African
American
Hispanic
Asian/Pacific Islander
Native American
Multi-Racial/Ethnic
Other
Location of Practice
Rural
Suburban
Urban
Other
Profession
Pediatrician
Family Practice
Registered Nurse
Nurse Practitioner
Other
Setting of Practice
Hospital
Clinic
Private Practice
University-Affiliated
Center
Other

Experimental
(%)
(n = 25)

Control
(%)
(n = 24)

Total
(%)
(n = 49)

4.0
20.0
36.0
28.0
12.0

41.7
33.3
20.8
4.2
0.0

22.4
26.5
28.6
16.3
6.1

32.0
68.0

25.0
75.0

28.6
71.4

64.0

87.5

75.5

8.0
16.0
4.0
0.0
4.0
4.0

4.2
4.2
4.2
0.0
0.0
0.0

6.1
10.2
4.1
0.0
2.0
2.0

44.0
12.0
44.0
0.0

8.3
50.0
41.7
0.0

26.5
30.6
42.9
0.0

72.0
8.0
4.0
4.0
12.0

70.8
0.0
0.0
29.2
0.0

71.4
4.1
2.0
16.3
6.1

4.0
52.0
20.0

37.5
8.3
12.5

20.4
30.6
16.3

8.0
16.0

41.7
0.0

24.5
8.2
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Table 2 (Continued)
Demographics Characteristics of Sample at Pre-Test as a Function of Treatment Group

Variable
Years in Practice
1-10
11-20
21-30
31-40
ASD Trainings
0
1-3
4-5
Change in Practice
Trainings
0
1-3
4-7

Experimental
(%)
(n = 25)

Control
(%)
(n = 24)

Total
(%)
(n = 49)

36.0
36.0
20.0
8.0

83.3
4.2
8.3
4.2

59.2
20.4
14.3
6.1

32.0
48.0
8.0

75.0
20.8
4.2

53.1
34.7
6.1

40.0
32.0
4.0

91.7
8.4
0.0

65.3
20.3
2.3

Exploratory Factor Analyses
The first exploratory factor analysis was conducted on the items pertaining to the
General Knowledge section (see Table 3). Using the eigenvalue-greater-than-one rule,
one factor was extracted, explaining 62.19% of the variance (Kaiser, 1958).
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Table 3
Exploratory Factor Analysis for General Knowledge Scale Items (Pre-Test)
________________________________________________________________________
Item
Factor
Communality Coefficient
1
________________________________________________________________________
Knowledge Area
Autism Spectrum Disorders
.999
.999
Early Warning Signs of ASD
.821
.673
Developmental Screeners
.413
.170
Autism-Specific Screeners
.545
.297
________________________________________________________________________
Trace

2.487

2.14

% of variance explained

62.19

62.19

________________________________________________________________________
n = 49
Note: All bolded coefficients within this factor had effect sizes greater than the cut-off
value of 0.3 recommended by Lambert and Durand (1975).
The second exploratory factor analysis was conducted on the Screening Patterns
section. Table 4 presents the results from this analysis. The factor analysis revealed two
factors. The three items in Subsection A represented one factor, and the three items in
subsection B represented another factor. The first factor was named Screening Patterns:
Developmental scale, and this factor explained 49.19% of the variance. The second factor
was named Screening Patterns: Autism-Specific scale, and this factor explained 24.44%
of the variance. The total scale explained 73.63% of the variance.
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Table 4
Exploratory Factor Analysis for Screening Scale Items (Pre-Test)
________________________________________________________________________
Item
Factor
Communality Coefficient
1
2
________________________________________________________________________
Ages & Stages*
.367
.483
.367
PEDS*
.088
.833
.701
CSBS DP*
.136
.823
.695
CHAT**
.968
.089
.944
M-CHAT**
.983
.145
.986
PDDST**
.454
.208
.249
________________________________________________________________________
Trace

2.948

1.467

3.943

% of variance explained

49.14

24.44

73.582

________________________________________________________________________
n = 49
Note: All bolded coefficients within this factor had effect sizes greater than the cut-off
value of 0.3 recommended by Lambert and Durand (1975), and had larger coefficients
than in the other factor.
* represent developmental screening instruments
** represent autism-specific screening instruments
The final exploratory factor analysis was conducted on the Potential Barriers
section. This factor analysis revealed two factors. The first two items (i.e., Insufficient
time and Lack of staff to assist with screenings) in the Potential Barriers section
represented one factor and, therefore, these items were labeled as Potential Barriers:
Time and Personnel Assistance scale. This factor explained 41.54% of the variance
(Kaiser, 1958). The next four items in the section (i.e., Insufficient information regarding
referral resources, Cost of screening instruments, Inadequate reimbursement, and
Concern regarding emotional impact on the family) represented another factor, and these
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items were labeled as Potential Barriers: Financial and Emotional Costs scale (see Table
5). This factor explained 18.42% of the variance. The total scale explained 59.96% of the
variance. The last item in the section (i.e., Belief that clinical impression is sufficient)
was not highly correlated with either factor; therefore, this item was removed from the
scale.
Table 5
Exploratory Factor Analysis for Potential Barriers Items (Pre-Test)
________________________________________________________________________
Item
Factor
Communality Coefficient
1
2
________________________________________________________________________
Insufficient Time
.989
.143
.999
Lack of Staff
.733
.151
.560
Insufficient Info. (referral resources)
.344
.510
.378
Cost of Instruments
-.015
.651
.424
Inadequate Reimbursement
.249
.840
.767
Concern regarding emotional impact
.106
.440
.204
Belief that clinical impression sufficient .234
.283
.135
________________________________________________________________________
Trace

2.908

1.290

3.469

% of variance explained

41.54

18.420

59.958

________________________________________________________________________
n = 49
Note: All bolded coefficients within this factor had effect sizes greater than the cut-off
value of 0.3 recommended by Lambert and Durand (1975), and had larger coefficients
than in the other factor.
Score Reliability of Pre-Test Measures
For each scale and subscale, score reliability coefficients were computed using
Cronbach’s alpha for each treatment group (i.e., control and experimental groups) and as
a whole. For the General Knowledge scale, Cronbach’s alpha was computed for (a) Pre-
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test scores from participants in the experimental group and the control group combined,
(b) Pre-test scores from participants in the experimental group only, and (c) Pre-test
scores from participants in the control group only. The same procedures were carried out
for the remaining scales on the questionnaire. Overall, the Cronbach’s alpha was high for
scores pertaining to all measures except for the Screening Patterns: Developmental scale
for the control group and the Potential Barriers: Financial and Emotional Costs scale for
the control group (see Table 6).
Table 6
Score Reliabilities (Cronbach’s Alpha) for all Measures by Treatment Group: Pre-Test
________________________________________________________________________
Scale
Experimental
Control
All
________________________________________________________________________
General Knowledge
.70
.84
.78
Screening Patterns: Developmental
.83
.49
.74
Screening Patterns: Autism-Specific
.92
.72
.84
Screening Patterns: Age of Patient
.99
.99
.99
Potential Barriers: Time & Personnel
.84
.88
.86
Potential Barriers: Fin. & Emot. Costs
.82
.43
.72
________________________________________________________________________
n = 49
Assessing Group Equivalence
Urban versus rural. To determine whether there was a difference in participants’
scores based on geographic region (i.e., urban versus rural), independent samples t-tests
were conducted. Prior to conducting these analyses, the normality assumption was
evaluated. Tables 7 and 8 present the skewness and kurtosis coefficients for each of the
pre-test scales for the urban and rural samples, respectively. According to Onwuegbuzie
and Daniel (2002), (a) standardized skewness (i.e., skewness divided by its standard
error) and kurtosis coefficients (i.e., kurtosis divided by its standard error) that lie within
±2 suggest no serious departures from normality; (b) coefficients outside this range but
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within the ±3 boundary signify slight departures from normality; and (c) standardized
coefficients outside the ±3 range indicate important departures from normality.
For the urban group, the standardized skewness and kurtosis coefficients indicated
that the following five scales did not depart from normality: (a) General Knowledge, (b)
Screening Patterns: Developmental, (c) Screening Patterns: Age of Patient, (d) Potential
Barriers: Time & Personnel Assistance, and (e) Potential Barriers: Financial & Emotional
Costs (see Table 7). In contrast, the Screening Patterns: Autism-specific scale scores were
both extremely positively skewed and indicated a leptokurtic distribution (i.e., more
peaked than the normal distribution). This finding was confirmed by the histograms (not
presented).
For the rural group, both the Screening Patterns: Developmental Scale scores and
Screening Patterns: Autism-Specific scale scores deviated from normality; both were
extremely positively skewed and indicated leptokurtic distributions (see Table 8).
Because the assumption of normality was violated for at least one group with respect to
the Screening Patterns: Developmental and Screening Patterns: Autism-Specific scales, a
nonparametric independent samples t-test (i.e., Mann-Whitney) was used for these two
scales. The Bonferroni adjustment was used to control for the inflation of Type I error.
Specifically, a Bonferroni-adjusted alpha value of .008 (i.e., .05/6) was used. The results
of these t-tests are presented in Table 9. From these results it can be seen that for the
General Knowledge scale, a statistically significant difference was found between urban
and rural participants. For the remaining scales, no statistically significant difference was
found between urban and rural participants.
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Table 7
Skewness and Kurtosis Coefficients for Pre-Test Scales: Urban Group (n = 8)
Screening
Patterns:
Age of
Patient

Potential
Barriers:
Time &
Personnel
Assistance

Potential
Barriers:
Financial
&
Emotional
Costs

General
Knowledge

Screening
Patterns:
Developmental

Screening
Patterns:
AutismSpecific

-.37

1.17

3.02

.73

-1.09

.33

Std. Error of
Skewness

.52

.52

.52

.54

.52

.52

Standardized
Skewness

-.71

2.25

5.81

1.35

-2.10

.63

.37

.77

8.45

-.82

.47

-1.49

1.01

1.01

1.01

1.04

1.01

1.01

.37

.76

8.37

-.79

.47

-1.48

Skewness

Kurtosis
Std. Error of
Kurtosis
Standardized
Kurtosis

Table 8
Skewness and Kurtosis Coefficients for Pre-Test Scales: Rural Group (n = 15)
Screening
Patterns:
Age of
Patient

Potential
Barriers:
Time &
Personnel
Assistance

Potential
Barriers:
Financial
&
Emotional
Costs

General
Knowledge

Screening
Patterns:
Developmental

Screening
Patterns:
AutismSpecific

.96

2.35

2.48

-.10

-.43

-.48

Std. Error of
Skewness

.43

.43

.43

.43

.43

.43

Standardized
Skewness

2.23

5.47

5.77

-.23

-1.00

-1.12

.82

6.18

5.69

-1.46

-.78

-.44

.83

.83

.83

.83

.83

.83

.99

7.45

6.86

-1.76

-.94

-.53

Skewness

Kurtosis
Std. Error of
Kurtosis
Standardized
Kurtosis

75

Table 9
T-Tests Comparing Participants’ Scores Based on Geographic Region: Pre-Test (n = 49)
________________________________________________________________________
Urban
Rural
Scale
M
SD
M
SD
t-value
U*
p-value
________________________________________________________________________
General Knowledge
9.00
2.08
7.27
2.03
2.88
.006
Screening (Developmental) 4.68 2.08 4.07 2.10
221.50 .131
Screening (Autism-specific) 3.53 1.61 3.43 1.01
263.50 .493
Screening (Age of Patient) 16.89 10.52 19.93 10.06
-.998
.324
Barriers (Time & Personnel) 6.53
1.81
5.77
1.89
1.395
.170
Barriers (Cost)
9.95
4.21 10.27
2.43
-.337
.738
________________________________________________________________________
* U denotes Mann-Whitney’s test statistic.
Experimental versus control. To determine whether there was a difference in the
selected outcomes between the experimental and control groups, a series of independent
samples t-tests was conducted. Prior to conducting this analysis, the normality
assumption was evaluated. Tables 10 and 11 present the skewness and kurtosis
coefficients for each of the pre-test scales for the experimental and control samples,
respectively. For the experimental group, the standardized skewness and kurtosis
coefficients indicated that the following four scales did not depart from normality: (a)
General Knowledge, (b) Screening Patterns: Age of Patient, (c) Potential Barriers: Time
& Personnel Assistance, and (d) Potential Barriers: Financial & Emotional Costs Scale.
In contrast, the Screening Patterns: Developmental scale was positively skewed and the
Screening Patterns: Autism-specific scale scores were both extremely positively skewed
and had a leptokurtic distribution (i.e., more peaked than the normal distribution). This
finding was confirmed by the histograms. For the control group, only the Screening
Patterns: Autism-Specific scale scores deviated from normality. Because the assumption
of normality was violated for at least one group with respect to the Screening Patterns:
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Developmental scale and the Screening Patterns: Autism-specific scale, a nonparametric
independent samples t-test (i.e., Mann-Whitney) was used for these two scales. The
results of these t-tests are presented in Table 12. These data indicate that no statistically
significant differences emerged.

Table 10
Skewness and Kurtosis Coefficients for Pre-Test Scales: Experimental Group (n = 25)
Screening
Patterns:
Age of
Patient

Potential
Barriers:
Time &
Personnel
Assistance

Potential
Barriers:
Financial
&
Emotional
Costs

General
Knowledge

Screening
Patterns:
Developmental

Screening
Patterns:
AutismSpecific

-.12

1.69

3.54

.60

-.95

.14

Std. Error of
Skewness

.46

.46

.46

.47

.46

.46

Standardized
Skewness

-.26

3.64

7.62

1.28

-2.05

.30

-.48

2.47

12.00

-1.02

-.03

-1.54

.90

.90

.90

.92

.90

.90

-.54

2.74

13.30

-1.11

-.04

-1.71

Skewness

Kurtosis
Std. Error of
Kurtosis
Standardized
Kurtosis
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Table 11
Skewness and Kurtosis Coefficients for Pre-Test Scales: Control Group (n = 24)

General
Knowledge

Screening
Patterns:
Developmental

Screening
Patterns:
AutismSpecific

Screening
Patterns:
Age of
Patient

Potential
Barriers:
Time &
Personnel
Assistance

Potential
Barriers:
Financial &
Emotional
Costs

1.02

1.32

2.12

-.18

-.37

-.50

Std. Error of
Skewness

.46

.46

.46

.47

.46

.46

Standardized
Skewness

2.22

2.87

4.61

-.38

-.80

-1.09

1.25

.32

3.84

-1.37

-.80

.18

.92

.92

.92

.92

.92

.92

1.36

.35

4.17

-1.49

-.87

.20

Skewness

Kurtosis
Std. Error of
Kurtosis
Standardized
Kurtosis

Table 12
T-Tests Comparing Participants’ Scores Based on Treatment Group: Pre-Test (n = 49)
________________________________________________________________________
Experimental
Control
Scale
M
SD
M
SD
t-value
U*
p-value
________________________________________________________________________
General Knowledge
8.60
2.18 7.25
2.05
2.23
.030
Screening (Developmental) 4.64
2.46 3.96 1.60
257.50 .325
Screening (Autism-specific) 3.40
1.41 3.54 1.10
254.50 .157
Screening (Age of Patient) 16.88 10.19 20.71 10.12
-1.31
.198
Barriers (Time & Personnel) 6.32
1.93
5.79 1.82
.986
.329
Barriers (Cost)
8.32
3.41
8.29
2.05
.035
.972
________________________________________________________________________
* U denotes Mann-Whitney’s test statistic.
Check of Normality Assumptions for Post-Test Scores
Urban and rural. The skewness and kurtosis coefficients were computed for each
of the post-test scales for the urban and rural samples, respectively. For the urban group,
the standardized skewness and kurtosis coefficients indicated that the following four
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scales did not depart from normality: (a) Screening Patterns: Developmental, (b)
Screening Patterns: Age of Patient, (c) Potential Barriers: Time & Personnel Assistance,
and (d) Potential Barriers: Financial & Emotional Costs. In contrast, the General
Knowledge scale scores had a leptokurtic distribution (i.e., more peaked than the normal
distribution) and the Screening Patterns: Autism-specific scale scores were both
positively skewed and had a leptokurtic distribution. This finding was confirmed by the
histograms (not presented). For the rural group, none of the six scales departed from
normality.
Experimental and control. Tables 13 and 14 present the skewness and kurtosis
coefficients for each of the post-test scales for the experimental and control groups,
respectively. For the experimental group, the standardized skewness and kurtosis
coefficients indicated that the following five scales did not depart from normality: (a)
General Knowledge, (b) Screening Patterns: Developmental, (c) Screening Patterns: Age
of Patient, (d) Potential Barriers: Time & Personnel Assistance, and (e) Potential
Barriers: Financial & Emotional Costs. In contrast, the Screening Patterns: Autismspecific scale scores were positively skewed. This finding was confirmed by the
histograms (not presented). For the control group, none of the six scales departed from
normality.
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Table 13
Skewness and Kurtosis Coefficients for Post-Test Scales: Experimental Group (n = 25)
Screening
Patterns:
Age of
Patient

Potential
Barriers:
Time &
Personnel
Assistance

Potential
Barriers:
Financial
&
Emotional
Costs

General
Knowledge

Screening
Patterns:
Developmental

Screening
Patterns:
AutismSpecific

-.03

-.11

1.98

.53

-1.24

.22

Std. Error of
Skewness

.62

.62

.62

.62

.62

.62

Standardized
Skewness

-.05

-.17

3.20

.85

-2.02

.36

1.55

-1.57

2.98

-1.07

2.01

-1.11

1.19

1.19

1.19

1.19

1.19

1.19

1.30

-1.31

2.51

-.90

1.69

-.93

Skewness

Kurtosis
Std. Error of
Kurtosis
Standardized
Kurtosis

Table 14
Skewness and Kurtosis Coefficients for Post-Test Scales: Control Group (n = 24)

General
Knowledge

Screening
Patterns:
Developmental

Screening
Patterns:
AutismSpecific

Screening
Patterns:
Age of
Patient

Potential
Barriers:
Time &
Personnel
Assistance

Potential
Barriers:
Financial &
Emotional
Costs

.05

.80

1.34

-.14

-1.52

-.30

Std. Error of
Skewness

.62

.62

.62

.62

.62

.62

Standardized
Skewness

.07

1.30

2.18

-.22

-2.46

-.49

-.98

-.62

1.42

-1.00

1.70

-1.00

1.19

1.19

1.19

1.19

1.19

1.19

-.82

-.52

1.19

-.84

1.42

-.84

Skewness

Kurtosis
Std. Error of
Kurtosis
Standardized
Kurtosis
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Post-Test Analyses
Score Reliability of Measures
For each scale and subscale, score reliability coefficients were computed using
Cronbach’s alpha for each treatment group (i.e., control and experimental groups) and as
a whole. For the General Knowledge scale, Cronbach’s alpha was computed for (a) Posttest scores from participants in the experimental group and the control group combined,
(b) Post-test scores from participants in the experimental group only, and (c) Post-test
scores from participants in the control group only. The same procedures were carried out
for the remaining scales on the questionnaire. Overall, the Cronbach’s alpha was high for
all measures except for the General Knowledge scale for the experimental group and the
Screening Patterns: Developmental for both groups and the groups combined (see Table
15).

Table 15
Score Reliabilities (Cronbach’s Alpha) for all Measures by Treatment Group: Post-Test
________________________________________________________________________
Measure
Experimental
Control
All
________________________________________________________________________
General Knowledge
.41
.82
.77
Screening Patterns: Developmental
.08
.63
.41
Screening Scale (subsection B)
.76
.89
.84
Screening Patterns: Age of Patient
.99
.99
.99
Potential Barriers: Time & Personnel
.94
.83
.88
Potential Barriers: Fin. & Emot. Costs
.82
.73
.77
________________________________________________________________________
n = 26

The first research question in this study was: What is the effect of the Autism
System of Care (ASC) training on use of developmental and autism-specific screening
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instruments by pediatric healthcare providers? To answer the first part of this research
question (i.e., effect of ASC training on use of developmental screening instruments), a
2X2 repeated measures ANOVA was conducted. Box’s M test indicated that the
assumption of equality of the covariance matrices was not violated (M = 5.24, p > .05).
The repeated measures ANOVA revealed no statistically significant interaction between
time and treatment group (F[1, 24] = 1.17, p > .05). Further, no statistically significant
main effect due to time was found (F[1, 24] = 0.13, p > .05). Finally, no statistically
significant difference was found (i.e., the between-subjects main effect) between the
treatment and control group (F[1, 24] = 4.92, p > .05). The experimental group’s scores
decreased (i.e., indicating a decline in the use of developmental screening instruments)
whereas the control group’s scores increased—not a desirable outcome. However, these
changes were not statistically significant. Additionally, while the mean score for the
experimental group decreased from 5.15 (SD = 2.64) at pre-test to 4.85 (SD = 1.41) at
post-test, the effect size associated with this decline was .15 which may be considered
small and representing chance.
To answer the second part of this research question (i.e., effect of ASC training on
use of autism-specific screening instruments), a 2X2 repeated measures ANOVA was
computed. Box’s M test indicated that the assumption of equality of the covariance
matrices appeared to be violated (M = 11.95, p < .05). However, the fact that the sample
sizes were equal did not give cause for concern (Stevens, 2002). The repeated measures
ANOVA revealed no statistically significant interaction between time and treatment
group (F[1, 24] = 1.07, p > .05). Further, no statistically significant main effect due to
time was found (F[1, 24] = 4.76, p > .05). Finally, no statistically significant difference
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was found (i.e., the between-subjects main effect) between the treatment and control
group (F[1, 24] = 0.71, p > .05). Both the experimental and control groups’ scores
increased in a similar fashion; therefore, the change was not statistically significant.
The second research question from this study was: What is the effect of the ASC
training on the use of developmental screening instruments in regard to age of patient? To
address this question, a Wilcoxon’s signed rank test was computed. The results of this
test are presented in Table 16. No statistically significant effect was found for any of the
age ranges.

Table 16
Wilcoxon Test for Screening Patterns: Age of Patients Scale Scores: Pre- and Post-Test
________________________________________________________________________
Age
Positive
Negative
Ties
Z
p-value
0-6 months
5
1
7
-1.63
.10
7-12 months
6
1
6
-1.89
.06
13-18 months
5
1
7
-1.63
.10
19-24 months
6
1
6
-1.89
.06
25-36 months
6
1
6
-1.89
.06
37-48 months
4
2
7
-.33
.74
Older than 48
3
2
8
.00
1.00
months
(n = 49)
The third research question from this study was: What is the effect of the Autism
System of Care training on pediatric healthcare providers’ perceived barriers to
increasing the use of screening instruments and/or referring patients? To address this
question, two 2 X 2 repeated-measures ANOVAs were computed. Box’s M test indicated
that the assumption of equality of the covariance matrices was not violated (M = 4.26, p >
.05). For the Potential Barriers: Time & Personnel Assistance Scale, the repeated
measures ANOVA revealed no statistically significant interaction between time and
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treatment group (F[1, 24] = 1.71, p > .05). Further, no statistically significant main effect
due to time was found (F[1, 24] = 0.00, p > .05). Finally, no statistically significant
difference was found (i.e., the between-subjects main effect) between the treatment and
control group (F[1, 24] = 1.69, p > .05).
For the Potential Barriers: Financial & Emotional Costs Scale, Box’s M test
indicated that the assumption of equality of the covariance matrices was not violated (M
= 6.97, p > .05). The repeated measures ANOVA revealed no statistically significant
interaction between time and treatment group (F[1, 24] = 3.21, p > .05). Further, no
statistically significant main effect due to time was found (F[1, 24] = 1.37, p > .05).
Finally, no statistically significant difference was found (i.e., the between-subjects main
effect) between the treatment and control group (F[1, 24] = 0.31, p > .05). For both
scales, the experimental group scores decreased (i.e., indicating that the set of barriers
decreased their likelihood to impede the use of screening instruments) whereas the
control group scores increased—a desirable outcome. However, these changes in scores
were not statistically significant.
The fourth research question was: What is the effect of the Autism System of
Care training on pediatric healthcare providers’ perceived levels of knowledge related to
Autism Spectrum Disorders? A 2 X 2 repeated-measures ANOVA was conducted to
address this question. Box’s M test indicated that the assumption of equality of the
covariance matrices was not violated (M = 0.79, p > .05). The repeated measures
ANOVA revealed no statistically significant interaction between time and treatment
group (F[1, 24] = 1.13, p > .05). Both the experimental and control groups’ scores
increased slightly from pre- to post-test; however, these increases in scores were not
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statistically significantly different from each other. However, a statistically significant
main effect due to time was found (F[1, 24] = 6.67, p < .05; ω2 = .18). The effect size
associated with the time main effect was small to moderate. Specifically, across groups,
general knowledge of ASD was higher after the intervention (M = 8.42, SD = 2.08) than
before (M = 7.77, SD = 2.20). Also, a statistically significant difference was found (i.e.,
the between-subjects main effect) between the treatment and control group (F[1, 24] =
11.39, p < .05; ω2 = .29). The effect size associated with this difference was moderate.
Specifically, across the pre-test and post-test, the experimental group (M = 9.23, SE =
.48) rated their general knowledge of ASD to be higher than did the control group (M =
6.96, SE = .48).
The fifth research question addressed in this study was: What is the effect of the
Autism System of Care training on the self-efficacy of pediatric healthcare providers
regarding their ability to screen accurately and refer a child suspected of having an
Autism Spectrum Disorder? To answer this research question, two separate 2 X 2
repeated-measures ANOVAs were conducted. Box’s M test indicated that the assumption
of equality of the covariance matrices was not violated (M = 1.98, p > .05). With regard
to the item, “Please indicate the age at which you believe it is possible to accurately
screen and refer a child suspected of having an Autism Spectrum Disorder,” the repeated
measures ANOVA revealed no statistically significant interaction between time and
treatment group (F[1, 23] = 0.64, p > .05). Further, no statistically significant main effect
due to time was found (F[1, 23] = 0.77, p > .05). Finally, no statistically significant
difference was found (i.e., the between-subjects main effect) between the treatment and
control group (F[1, 23] = 3.09, p > .05).
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With regard to the item “Please indicate the age at which you believe you are able
to accurately screen and refer a child suspected of having an Autism Spectrum Disorder,”
another repeated measures ANOVA was conducted. Box’s M test indicated that the
assumption of equality of the covariance matrices was not violated (M = 3.75, p > .05).
The repeated measures ANOVA revealed no statistically significant interaction between
time and treatment group (F[1, 22] = 0.60, p > .05). Further, no statistically significant
main effect due to time was found (F[1, 22] = 0.48, p > .05). However, a statistically
significant difference was found (i.e., the between-subjects main effect) between the
treatment and control group (F[1, 22] = 7.13, p < .05; ω2 = .20). The effect size
associated with this difference was moderate. Specifically, across the pre-test and posttest, the experimental group (M = 17.34, SE = 2.06) believed that they could accurately
screen a child suspected of having an ASD at a lower age than did the control group (M =
24.81, SE = 1.89).
The sixth research question was: What is the relationship between pediatric
healthcare providers’ perceived barriers to utilizing screening instruments and their actual
use of developmental and autism-specific screening instruments before and after
completion of the training? To address this research question, two Spearman rank (order)
correlation coefficients were conducted (i.e., for pre- and post-test scores). For pre-test
scores, no statistically significant relationship was found between barriers associated with
time and personnel assistance and (a) use of developmental screening instruments (rs =
.10, p > .05), and (b) use of autism-specific screening instruments (rs = .11, p > .05).
Further, no statistically significant relationship was found between barriers associated
with financial and emotional costs and (a) the use of developmental screening
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instruments (rs = .13, p > .05), and (b) the use of autism-specific screening instruments (rs
= .05, p > .05).
For post-test scores, no statistically significant relationship was found between
barriers associated with time and personnel assistance and (a) use of developmental
screening instruments (rs = -.26, p > .05), and (b) use of autism-specific screening
instruments (rs = -.12, p > .05). Further, no statistically significant relationship was found
between barriers associated with financial and emotional costs and (a) the use of
developmental screening instruments (rs = -.12, p > .05), and (b) the use of autismspecific screening instruments (rs = -.31, p > .05).
The seventh and final research question from this study was: What is the
relationship between perceived barriers to utilizing screening instruments and the use of
developmental screening instruments in regard to age of patients before and after
completion of the training? To address this final research question, a series of Spearman
rank correlation coefficients was computed for both pre- and post-test scores.
Specifically, a Bonferroni-adjusted alpha value of .007 (i.e., .05/7) was used to reflect the
fact that seven correlations were computed. No statistically significant relationship was
found between barriers associated with time and personnel assistance and barriers
associated with financial and emotional costs and the age of patients screened for both
pre- and post-test scores. Tables 17 and 18 present the Spearman rank correlation
coefficients for pre-test and post-test scores, respectively.
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Table 17
Spearman Rank Correlation Coefficients: Pre-Test (n = 49)
Age of Patient

0-6 months
7-12 months
13-18 months
19-24 months
25-36 months
37-48 months
Older than 48 months
* p < .05

Potential Barriers:
Time & Personnel
Assistance
-.13
-.12
-.10
-.11
-.15
-.13
-.15

Potential Barriers:
Financial & Emotional
Costs
.09
.10
.06
.03
-.03
-.02
-.08

Table 18
Spearman Rank Correlation Coefficients: Post-Test (n = 26)
Age of Patient

0-6 months
7-12 months
13-18 months
19-24 months
25-36 months
37-48 months
Older than 48 months
* p < .05

Potential Barriers:
Time & Personnel
Assistance
-.13
-.13
-.15
-.15
-.16
-.21
-.29
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Potential Barriers:
Financial & Emotional
Costs
-.09
-.10
-.07
-.07
-.11
-.14
-.21

Chapter 5
Discussion
Summary of Study
The present study was conducted to explore the effectiveness of the Autism
System of Care (ASC) trainings by measuring change in pediatric healthcare providers’
methods of identifying young children at-risk for autism spectrum disorders (ASD). The
principal investigator developed pre- and post-test questionnaires to measure change in
participants’ screening practices in relation to ASD. This study was novel because it was
a pilot study whereby the researcher developed a questionnaire based specifically on the
ASC training to determine the training’s effect on participants’ methods of identifying
children with ASD. A pretest-posttest nonequivalent-groups design was used. This design
was chosen because the experimental and control groups were naturally assembled
groups, and therefore, such a design was the most practical one for this study. In addition,
this design enabled the researcher to gain insight on potential changes over time among
the participants in the experimental group and the control group. In this chapter, a
summary of results is presented, implications of the results are discussed, limitations are
examined, and suggestions for future research are provided.
Summary of Results
Prior to examining the highlights from Chapter 4, it is important for the reader to
put the findings from this study in the proper context. Based on the limited number of
participants who completed the ASC trainings, and subsequently, completed both the pre89

and post-test questionnaires, it is difficult to determine if the relative lack of change from
pre- to post-test was due to an ineffectual training, or if the lack of change is due mainly
to the relatively small sample size in the study. Unfortunately, no statistically significant
differences were found when examining the pre- and post-test scores of the participants.
Therefore, the hypotheses presented in the introduction of this document that stated that
the ASC trainings would impact participants’ practices in relation to ASD and early
screening were not confirmed.
Notable findings from the measures. The results from the measures administered in
this study produced some interesting findings. Although these findings were not
statistically significant, it is believed that the findings are clinically significant. For the
experimental group and the control group, scores on the General Knowledge scale were
higher at post-test compared to pre-test scores. In other words, participants from the
experimental group and the control group tended to rate their knowledge of autism
spectrum disorders higher on the post-test than their ratings on the pre-test. This was an
encouraging finding as a primary goal of the study was to increase participants’
knowledge of autism spectrum disorders. As cited in the section of this document that
reviews the related literature, there are significant implications for children with ASD
who are identified at young ages. The outcome for these children is significantly
improved when they are identified and receive supports and services early in their
development (Dawson et al., 2000; Dawson & Osterling, 1997; Filipek et al., 2000; Oser
& Shaw, 2001; Wetherby et al., 2004).
Other notable findings from the study revealed that across the pre- and post-test
scores, the experimental group rated their general knowledge of ASD to be higher than
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did the control group, and they believed they could accurately screen a child suspected of
having an ASD at a lower age than did the control group. However, this finding is likely
due to the differences in experience between the two groups. That is, the average number
of years in practice for the participants in the experimental group was 17.6 years, whereas
the average number of years in practice for the control group was only 6.4 years.
Although it was hoped that the experimental group and the control group would be
similar in all demographic variables for the purposes of this study, it is encouraging to
find that in this study practitioners’ knowledge of ASD was associated with increased
with experience. This finding indicates a need for more instruction early on in physicians’
training regarding autism spectrum disorders and the importance of early identification
and intervention. Material on ASD and various developmental and autism-specific
screening measures could be incorporated in didactic trainings throughout medical school
and/or residency training programs. Potential barriers to implementing these “best
practices” also could be addressed early in physicians’ training to increase their ability to
overcome these frequent barriers to early screening.
The pre-test examination of score reliabilities for each scale exhibited important
results. The Cronbach’s alpha was high for scores on all scales except for the Screening
Patterns: Developmental scale and the Potential Barriers: Financial and Emotional Costs
scale for the control group. The Screening Patterns: Developmental scale assessed
participants’ frequency of use of developmental screening instruments, and the Potential
Barriers: Financial and Emotional Costs scale assessed the potential financial barriers and
emotional barriers (e.g., impact of diagnosis on family) to utilizing screening instruments.
However at post-test, the Cronbach’s alpha was moderate for the Developmental scale

91

and high for the Potential Barriers: Financial and Emotional Costs scale for the control
group. Therefore, the scores on these scales were included in this study.
Sixth question. For post-test scores, no statistically significant relationship was
found between barriers associated with time and personnel assistance and (a) use of
developmental screening instruments, and (b) use of autism-specific screening
instruments. Further, no statistically significant relationship was found between barriers
associated with financial and emotional costs and (a) the use of developmental screening
instruments, and (b) the use of autism-specific screening instruments. Although none of
these relationships were statistically significant, it should be noted that two of these
correlations (i.e., the use of developmental screening instruments and time and personnel
assistance barriers, and the use of autism-specific screening instruments and the financial
and emotional costs barriers) appear to represent a non-trivial (i.e., moderate) association.
Seventh question. At pre-test, the relationship between Potential Barriers: Time
and Personnel Assistance and the use of developmental screening instruments at each age
level of patients (e.g., 0-6 months, 7-12 months) was both statistically non-significant and
small. However, the fact that all seven correlations were negative is notable because it
suggests a consistent inverse relationship between these two variables regardless of the
age of the patient. Furthermore, although at post-test the relationship between both
Potential Barriers scales and the use of developmental screening instruments at each age
level of patients was non-significant and small, it is notable that all 14 correlations were
negative.
Implementation integrity. The design of this study was selected with the intention that
the implementation would be consistent and stable across training sessions. Fortunately,
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no deviations from the original plan occurred, as 100% of the components were fully
covered across the three training sessions. Therefore, the implementation integrity in this
study was strong as each participant did receive the same type of training.
Effectiveness of the intervention. Overall, the results of this study revealed no
statistically significant effects from the ASC trainings based on participants’ responses to
the Pediatric Healthcare Provider Self-Report Questionnaire. However, because of the
small sample size, it cannot be definitively known whether these results were due to the
lack of effectiveness of the trainings. Directions for future interventions and research will
be discussed later in this chapter.
Implications of the Results
Although this study did not produce statistically significant findings regarding the
effect of the ASC trainings on pediatric healthcare providers’ practice, some implications
from this study have emerged. For example, it is important to point out that there were
positive changes in participants’ scores from pre- to post-test. For example, on average,
participants from the experimental group and the control group rated their use of autismspecific screeners higher at post-test as compared to pre-test. Furthermore, when
examining use of developmental screening instruments regarding age of patient, on
average, participants in the experimental group screened patients in all age categories
more frequently than did participants from the control group. This trend might suggest
that the ASC training had an impact on the practitioners’ screening practices. After
completion of the training whereby participants learned about the importance of early
identification and use of screening instruments with all young patients, these practitioners
increased their frequency of use of screening instruments with patients of all ages.
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However, there were differences between experimental group and control group
regarding frequency of use of screening instruments at pre-test. This finding may be
partly explained by the difference in years in practice between the experimental group
and the control group as participants in the experimental group had significantly more
years in practice compared to the control group. Through experience practicing medicine,
practitioners may become more aware of the need for screening their young patients.
Given the substantial literature that supports the positive effects of early identification of
children with ASD, it is encouraging that experienced practitioners are screening their
patients. However, if practitioners understand the importance of early identification early
in their own training, more practitioners will be able to identify more children earlier in
their development.
When examining perceived barriers to screening children, participants in the
experimental group had a slight change in pre- to post-test scores which indicated a
decreased likelihood of the barriers preventing the utilization of screening instruments.
Specifically, on the Potential Barriers: Time & Personnel Assistance scale, scores
decreased from 6.77 to 6.38 for the experimental group. On the Potential Barriers:
Financial & Emotional Costs scale, scores decreased from 8.62 to 7.15 for the
experimental group. For the control group, scores on both of these scales actually
increased slightly from pre- to post-test (i.e., 5.62 to 6.00, and 8.23 to 8.54, respectively).
This is a positive trend because it suggests that the ASC training may have had an effect
on participants’ perceived barriers to utilizing screening instruments with their patients.
In other words, after completion of the training, participants did not rate the barriers as
high in terms of hindering screening practices.
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Participants from the experimental group and the control group had changes in
scores on the General Knowledge scale, and although the changes were not statistically
significant, there was a positive trend. For example, experimental group scores increased
from 8.77 to 9.69 from pre- to post-test, indicating an increase in their perceived
knowledge of ASD. The control group scores increased, from 6.77 to 7.15, indicating a
slight increase in their perceived knowledge of ASD as well. Because there was an
increase on the General Knowledge scale for the experimental group and the control
group, this suggests that participants from both groups had an increase in their knowledge
related to ASD. This may indicate that practitioners are gaining knowledge regarding
ASD from multiple sources. It would be advantageous to ascertain in what capacity
practitioners are acquiring this knowledge so that these efforts can be strengthened and
continued.
Limitations
Although the initial intent of the Autism System of Care grant was to increase
awareness of ASD and autism-specific screeners, the objective of the grant changed
during the course of the funding year. A Health Care Task Force was responsible for the
funding and was the main driver of changing the focus of the grant. Therefore, the focus
switched from autism-specific information and screening instruments to general
developmental screening instruments and changing practice. Therefore, the training
sessions ultimately focused less on autism-specific instruments, and more on general
developmental screeners and changing screening practice. This change in focus may
explain in part why statistically significant changes were not found through this study.

95

The original goal of the study was to secure a minimum of 100 professionals to
participate in the ASC trainings, and subsequently in this study. It was anticipated that
virtually all participants in the trainings would complete the pre-test questionnaire.
However, it was expected that approximately 50 participants would complete both the
pre- and post-questionnaire because research demonstrates the average response rate to
mail surveys for physicians is 54% (Asch et al., 1997). Unfortunately, although the grant
for the ASC trainings specified that a minimum of 100 practitioners would be trained,
this number was not obtained. Therefore, the number of potential participants available
for this study was decreased significantly. Out of the 36 total practitioners who
participated in the ASC trainings, 25 completed the pre-test questionnaire and 13
completed both the pre- and post-test questionnaires. Although this study acquired a very
similar response rate compared to the average response rate for physicians (52% versus
54%), the small overall sample size was a significant limitation of this study. If a larger
initial number of practitioners had completed the ASC training, this would have been an
adequate response rate and might have produced some more statistically significant
results.
Although Halfon et al. (2000) found that 65% AAP members surveyed reported
less than adequate training, oftentimes it is difficult to attract physicians to trainings for a
multitude of reasons. One primary reason is lack of time to fit a training session into an
already busy work schedule. The literature indicates that less than half of physicians
agree that there is adequate time to perform developmental screenings during typical
well-child visits (Sices et al., 2003). Another difficulty may stem from the belief that one
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can identify children with developmental delays without the use of screening instruments
and therefore, they do not need additional training (Sices et al., 2003).
Several methods were implemented in an attempt to attract participants. To
address the issue of time constraints, the trainings were scheduled at times that were
thought to be most convenient for practitioners, such as in the evening after their work
day was complete, or during their lunch hour. To address the potential belief that
practitioners already are knowledgeable about ASD and early screening instruments,
pediatricians who took part in the ASC workgroup attempted to communicate the
importance of the ASC trainings to colleagues. Furthermore, in an attempt to acquire
more participants, physicians were awarded one Continuing Medical Education (CME)
credit for completing the ASC training. Registered nurses and nurse practitioners who
completed the training were awarded one Continuing Education Unit (CEU). In addition,
a complimentary dinner was provided at each training. However, based on the small
number of pediatric healthcare providers who participated in the Autism System of Care
training, it is apparent that more must be undertaken to attract providers to trainings that
will enable them to improve their current practices. The small sample size was a threat to
external validity because the findings cannot be generalized to the population. Also, the
small sample size limited statistical power and therefore made it difficult to find
statistically significant results.
Another limitation of this study was the method by which participants were
placed in groups (i.e., experimental and control). Random selection and assignment were
not possible in the current study because participants who registered for the ASC training
were automatically placed in the experimental group, whereas the control group consisted
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of those practitioners who were not invited to participate in the ASC training for the
singular reason that the trainings were not held near their geographic region. Therefore,
the study cannot claim a true experimental design; thus the study utilized a quasiexperimental design. Differential selection of participants, also known as selection bias,
presented a threat to internal validity because there was an important distinction between
participants from the experimental group and participants from the control group (Best &
Kahn, 2003). That is, there was a statistically significant difference in both age and
number of years in practice between the two groups, with participants in the experimental
group being older and possessing more years in practice compared to the control group.
This difference between groups could have impacted the results of this study; therefore, it
cannot be determined definitively whether the outcome data obtained from the groups
were due to the ASC training, selection bias, or a combination of the two factors.
Furthermore, it is important to point out some discrepancies in the demographics
of the participants from this study. Significantly more women participated in the training
compared to men (71.4% vs. 28.6%). In addition, the participants were predominately
White (Non-Hispanic) and defined themselves as pediatricians (75.5% and 71.4%,
respectively). Because of the skewed demographics, the results of this study may not
generalize to other types of pediatric healthcare providers (e.g., males, non-Whites, and
nurse practitioners).
It is important to mention that this was a pilot of the Autism System of Care
training. Therefore, it is hypothesized that issues may arise with the suitability of the
material to be presented in the training. Specifically, it may be beneficial to obtain
feedback from participants to determine which material was least effective and could be
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removed from the training, and what was most effective and could therefore be expanded.
Also, it would be advantageous to obtain feedback regarding the group and individual
activities. Then, as needed, the ASC training could be reworked so that it is most
effective in supporting practitioners in changing their practices. Finally, instrumentation
may have been a threat to the internal validity of this study. Because the questionnaire
was designed to obtain information from participants via self-reports, the accuracy of the
data cannot be verified or known with complete confidence. However, the score
reliability of each scale was assessed via Cronbach’s alpha. Also, construct-related
validity was examined via factor analysis.
Considerations for Future Research
First and foremost, to determine whether the Autism System of Care training is
truly effective in facilitating pediatric healthcare providers to change their practice
regarding early screening, the trainings must be carried out with a larger number of
participants. It also could be beneficial to have the participants complete the post-test
questionnaire at an additional time several months following the original post-test
administration. As the literature has shown, change is a slow process; therefore, it is
likely that more significant changes would occur over a longer duration of time.
Furthermore, in addition to the use of a pre- and post-test questionnaire, qualitative data
could be collected through semi-structured interviews with participants to ascertain
supplementary information regarding their knowledge of ASD, self-efficacy, use of
screening instruments, and the potential barriers to the routine use of these instruments.
Given the importance of early identification and intervention for children with
developmental delays such as autism spectrum disorders, it is critical that professionals
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who are in the position to identify these children obtain the knowledge and resources
necessary to provide children with the supports and services needed as early in their
development as possible. Based on the results of this study, it is unclear whether or not
the ASC trainings would have been effective had there been a larger sample size.
However, based on previous literature on the effectiveness of trainings in changing
practice, it may be beneficial to consider other methods of changing practice.
An effectual start may be to incorporate training regarding ASD, early warning
signs, and the importance of early, routine screening into medical school training as well
as residency training programs. This effort could involve the combination of didactic
training as well as supervisors and chief residents modeling these “best practices” with
the use of routine, early screenings of all children. Furthermore, information regarding
the importance of early identification of ASD could be disseminated during Grand
Rounds, journal clubs, and other types of meetings with medical students and residents.
This information also could be disseminated and discussed at national conferences and
through newsletters, brochures, or handouts.
Final Thoughts
The evaluation of the Autism System of Care training provided the principal
investigator with a novel opportunity to understand the effect that the intervention had on
pediatric healthcare providers’ practice. While the results of the study did not suggest that
the ASC trainings had any major impact on practitioners’ screening practices with young
children, encouraging trends were found through the study. It is critical that pediatric
healthcare providers are armed with the knowledge and resources necessary to identify
children with developmental delays early in their development. An abundance of
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literature supports the positive impact of early identification and intervention on young
children’s developmental outcomes. Although it is recommended by the American
Academy of Pediatrics (AAP) that all infants and children are screened for developmental
delays or disabilities (AAP, 2001), the literature points out a number of barriers that
prevent practitioners from carrying out these “best practices.”
It is quite clear that changes must occur for practitioners to use developmental
screeners routinely with their young patients. To assist practitioners with this change,
knowledge and practical support must be provided. Therefore, it may first be necessary to
identify and overcome the barriers to acquiring this knowledge and support, whether in
the form of trainings or otherwise. Then, the barriers to utilizing screening instruments to
identify children with ASD and other developmental disabilities can be dismantled, and
change in practice can truly take place.
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Appendix A: Autism System of Care Flyers

Statewide Autism System of Care
This publication was commissioned, funded by the Florida Developmental Disabilities Council, Inc., and
produced through funding provided by the United States Department of Health and Human Services,
Administration for Developmental Disabilities

Screening and Surveillance of Autism and Related Disabilities
How to Change One’s Clinical Practice
Presenter
Quimby E. McCaskill, M.D., MPH, FAAP
Assistant Professor of Pediatrics
Associate Director of the Community Pediatrics Training Initiative
at the University of Florida

6 p.m. to 7 p.m., Wednesday, May 4, 2005
University of South Florida- Florida Mental Health Institute Westside A & B
13301 Bruce B. Downs Blvd. Tampa

Dinner will be provided
•
•
•
•
•
•
•

Learner Objectives
Discuss why early screening and surveillance are important.
Define red flags of autism spectrum disorders.
Review developmental screening tools.
List barriers preventing change in practice.
Describe model for improving screening practices.
Create aim statement for changing practice.
Develop next steps to initiate practice change.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University
of South Florida College of Medicine and USF Florida Mental Health Insitute. The University of South Florida
College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The
University of South Florida College of Medicine designates this educational activity for a maximum of 1.0 category
1 credits towards the AMA physician’s Recognition Award. Each physician should claim only those credits that
he/she actually spent in the activity.
This activity for 1 contact hour is provided by the University of South Florida College of Nursing, which is accredited as a
provider of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation.
Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

RSVP by 4-27-05 to Craig Silverstein at 813-974-6464 or
csilverstein@fmhi.usf.edu
Sponsored by

College of Medicine and College of Nursing
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Appendix A: (Continued)

Statewide Autism System of Care
This publication was commissioned, funded by the Florida Developmental Disabilities Council, Inc., and
produced through funding provided by the United States Department of Health and Human Services,
Administration for Developmental Disabilities

Screening and Surveillance of Autism and Related Disabilities
How to Change One’s Clinical Practice
Presenter
Flora Robinson, M.D.

Developmental Pediatrician
University of South Florida-All Children’s Hospital

3:00 p.m. - 4:00 p.m., Wednesday, May 18, 2005
Duval County Health Department
515 W. 6th Street, Jacksonville
(2nd Floor, Conference Room A & B)

•
•
•
•
•
•

Learner Objectives

Discuss why early screening and surveillance are important.
Define red flags of autism spectrum disorders.
Review developmental screening tools.
List barriers preventing change in practice.
Describe model for improving screening practices.
Create aim statement for changing practice.
• Develop next steps to initiate practice change.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of
the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship
of the University of South Florida College of Medicine and USF Florida Mental Health Insitute. The
University of South Florida College of Medicine is accredited by the ACCME to provide continuing
medical education for physicians. The University of South Florida College of Medicine designates this
educational activity for a maximum of 1.0 category 1 credits towards the AMA physician’s
Recognition Award. Each physician should claim only those credits that he/she actually spent in the
activity.
This activity for 1 contact hour is provided by the University of South Florida College of Nursing, which is
accredited as a provider of continuing education in nursing by the American Nurses Credentialing Center’s
Commission on Accreditation. Each nurse should claim only those hours of credit that he/she actually spent
in the educational activity.

RSVP by 4-28-05 to Craig Silverstein at 813-974-6464 or
csilverstein@fmhi.usf.edu

Sponsored by

College of Medicine and College of Nursing
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Appendix A: (Continued)

Statewide Autism System of Care
This publication was commissioned, funded by the Florida Developmental Disabilities Council, Inc., and
produced through funding provided by the United States Department of Health and Human Services,
Administration for Developmental Disabilities

Screening and Surveillance of Autism and Related Disabilities
How to Change One’s Clinical Practice
Presenter
Quimby E. McCaskill, M.D., MPH, FAAP

Assistant Professor of Pediatrics
Associate Director of the Community Pediatrics Training Initiative
at the University of Florida

Noon to 1 p.m., Wednesday, June 1, 2005

Hendry Regional Medical Center - Conference Room
500 West Sugarland Highway (State Road 27)

Lunch will be provided
•
•
•
•
•
•
•

Learner Objectives
Discuss why early screening and surveillance are important.
Define red flags of autism spectrum disorders.
Review developmental screening tools.
List barriers preventing change in practice.
Describe model for improving screening practices.
Create aim statement for changing practice.
Develop next steps to initiate practice change.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University
of South Florida College of Medicine and USF Florida Mental Health Insitute. The University of South Florida
College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The
University of South Florida College of Medicine designates this educational activity for a maximum of 1.0 category
1 credits towards the AMA physician’s Recognition Award. Each physician should claim only those credits that
he/she actually spent in the activity. This activity for 1 contact hour is provided by the University of South Florida
College of Nursing, which is accredited as a provider of continuing education in nursing by the American Nurses
Credentialing Center’s Commission on Accreditation. Each nurse should claim only those hours of credit that
he/she actually spent in the educational activity.
Presented in cooperation with Hendry Regional Medical Center and Hendry County Health Department
RSVP on or before Friday, May 13 to Sue Reese (863) 674-4056, ext. 157 or
Suzette_Reese@doh.state.fl.us

College of Medicine and College of Nursing
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Appendix B: Pediatric Healthcare Provider Self-Report Questionnaire
Pediatric Healthcare Provider Self-Report Questionnaire
Purpose: As part of a multidisciplinary collaborative through the University of South Florida, this instrument was
designed to obtain information regarding screening and referral patterns of healthcare providers as well as potential
barriers to early screening and referral for Autism Spectrum Disorders (ASD).
ASD includes: autistic disorder, Asperger syndrome, pervasive developmental disorder- not otherwise specified (PDDNOS), Rett syndrome, and childhood disintegrative disorder.

General Information
Please rate your overall knowledge of:

Poor

Fair

Good

Excellent

1. Autism Spectrum Disorders (ASD)

1

2

3

4

2. Early warning signs of ASD

1

2

3

4

3. Developmental screening instruments* (e.g., ASQ, PEDS)

1

2

3

4

4. Autism-specific screening instruments* (e.g., CHAT, M-CHAT)
1
2
3
4
*Note. This refers to use of the entire instrument and does not include use of only a few items from the instrument.
5. Please indicate the age at which you believe it is possible to accurately screen and refer a

______ months

child suspected of having an Autism Spectrum Disorder:
6. Please indicate the age at which you believe you are able to accurately screen and refer a

______ months

child suspected of having an Autism Spectrum Disorder:

II. Screening Patterns
A) How often do you use the following
developmental screening instruments:

Never
(0%)

Rarely
(1-19%)

Sometimes
(20-49%)

Usually
(50-99%)

Always
(100%)

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Never
(0%)

Rarely
(1-19%)

Sometimes
(20-49%)

Usually
(5099%)

Always
(100%)

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Never
(0%)

Rarely
(1-19%)

Sometimes
(20-49%)

Usually
(5099%)

Always
(100%)

0-6 months

1

2

3

4

5

7-12 months

1

2

3

4

5

13-18 months

1

2

3

4

5

19-24 months

1

2

3

4

5

25-36 months

1

2

3

4

5

37-48 months

1

2

3

4

5

Older than 48 months

1

2

3

4

5

1. Ages & Stages Questionnaires (Bricker & Squires)
2. Parents’ Evaluations of Developmental Status (PEDS;
Glascoe)
3. Communication and Symbolic Behavior Scales
Developmental Profile Infant-Toddler Checklist (CSBS
DP; Wetherby & Prizant)
B) How often do you use the following
autism-specific screening instruments:
1. Checklist for Autism in Toddlers (CHAT; BaronCohen, Allen, & Gillberg)
2. Modified Checklist for Autism in Toddlers (M-CHAT;
Robins, Fein, & Barton)
3. Pervasive Developmental Disorder Screening Test
(PDDST; Siegel)
C) How often do you use developmental screening
instruments with patients in the following age ranges:
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Appendix B: (Continued)
III. Potential Barriers to Utilizing Screening Instruments
Please indicate the extent to which each item is likely or
unlikely to impede your use of screening instruments (e.g.,
PEDS).
1. Insufficient time

Unlikely

Somewhat
Unlikely

Somewhat
Likely

Very Likely

1

2

3

4

2. Lack of staff to assist with screenings

1

2

3

4

3. Insufficient information regarding referral resources

1

2

3

4

4. Cost of screening instruments

1

2

3

4

5. Inadequate reimbursement

1

2

3

4

6. Concern regarding emotional impact on the family

1

2

3

4

7. Belief that clinical impression is sufficient

1

2

3

4

IV. Demographics
Age:

<30

Gender:

Male

Race:

31-40

41-50

51-60

>60

Female

White (Non-Hispanic)

Black/African American

Hispanic

Native American

Multi-Racial/Ethnic

Other

Location
of practice:

Rural

Suburban

Urban

Profession:

Pediatrician

Family Practice

Registered Nurse

Asian/Pacific Islander

Other

Nurse Practitioner

Other

Subspecialty (if applicable): ____________________

Setting
of practice:

Hospital

Clinic

Private Practice

University-Affiliated Center

Other

Years in practice: ______

Number of trainings
completed related to: Autism Spectrum Disorders: ______

Changing practice/service delivery: ______

Thank you for completing this questionnaire
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Appendix C: Implementation Checklist

Autism System of Care Training- Implementation Checklist
Trainer: ____________________

Date: ______________

Reviewer: __________________
ASC Training Content:

Yes

Reminded participants about importance of completing
questionnaire and turning it in
Reviewed 7 Learning Objectives
Discussed “triad of impairments” in autism
Discussed all 8 “red flags” of autism
Reviewed indicators for immediate evaluation
Reviewed average age of diagnosis & recommended
age
Discussed importance of using screening instruments
Discussed importance of early screening/intervention
Reviewed 5 recommended general screening
instruments
Reviewed 3 autism-specific screening instruments
Detailed review of PEDS
Detailed review of Ages and Stages Questionnaire
(ASQ)
Reviewed AAP’s screening recommendations
Reviewed perceived and concrete barriers to screening
Reviewed Model for Improvement (Aim, Measures,
Ideas)
Discussed the 5 criterion of effective aim statements
117

Partially

No

Appendix C: (Continued)
Reviewed “Plan, Do, Study, Act” Cycles
Discussed measurement and data collection
Discussed 5 steps in approaching barriers
Reviewed example of change in practice to increase
early screening
Participants completed Individual 10-minute activity
Reviewed “Tips for Success”
Reviewed resources (e.g., websites, articles, books)
Addressed 7 Learning Objectives
Reminded participants of follow-up questionnaire and
importance of completing and returning
Obtain presenter’s comments (e.g., How do you feel the training went? Is there any part
of the training where you feel more time should be spent, Is there any material that
should be added? Removed?)

________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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